Trials · 491 open trials
Recruiting trials
Each list comes from ClinicalTrials.gov, the official US trial registry. Every compound shows the date we fetched its list.
A listing is not a recommendation. Trials have strict eligibility rules. Talk to your doctor and read the official record.
5-Amino-1MQ
No open trials in the snapshot of .clinicaltrials.gov
Apomorphine
Snapshot of .clinicaltrials.gov
NCT07257861
Interest of Continuous Subcutaneous Apomorphine in Parkinsonian Patients at the End of Life
Phase: Not stated · Sponsor: Centre Hospitalier Régional d'Orléans · Status: Recruiting
Countries: France
US states: none listed
NCT07422675
SAD Study in Patients With Parkinson's Disease and Motor Fluctuations
Phase: Phase 1 · Sponsor: Serina Therapeutics · Status: Recruiting
Countries: United States, Australia
US states: Colorado, Florida, Michigan
NCT07145190
SL-START - SubLingual Apomorphine Schemes of TitrAtion in Real-world Treatment
Phase: Not stated · Sponsor: Bial - Portela C S.A. · Status: Recruiting
Countries: Germany
US states: none listed
NCT07402928
Optimistic and Pessimistic Dopamine Signals in the Human Brain: a Mapping and Modelling Study in Health and Parkinson's Disease
Phase: Not stated · Sponsor: Danish Research Centre for Magnetic Resonance · Status: Recruiting
Countries: Denmark
US states: none listed
NCT07219927
Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States:
Phase: Not stated · Sponsor: Supernus Pharmaceuticals, Inc. · Status: Recruiting
Countries: United States
US states: California, Florida, New York
NCT04957095
Motor Network Physiology
Phase: Not applicable · Sponsor: University of Texas Southwestern Medical Center · Status: Recruiting
Countries: United States
US states: Texas
NCT05072015
Systematic Follow up of Second Line Treatments for Parkinson's Disease (Deep Brain Stimulation, Apomorphin Pump, Duodopa Pump)
Phase: Not stated · Sponsor: University Hospital, Strasbourg, France · Status: Not yet recruiting
Countries: France
US states: none listed
NCT05213169
Apomorphine in Severe Brain-injured Patients
Phase: Phase 2/Phase 3 · Sponsor: University of Liege · Status: Recruiting
Countries: Belgium, Spain
US states: none listed
NCT03911726
Do Antipsychotic Agents Induce Supersensitivity in Humans: A Combined PET/MRI Study in Patients With Schizophrenia
Phase: Not applicable · Sponsor: Central Institute of Mental Health, Mannheim · Status: Recruiting
Countries: Germany
US states: none listed
BPC-157
Snapshot of .clinicaltrials.gov
NCT07803250
Impact of BPC-157 on Recovery Following Rotator Cuff Repair Surgery
Phase: Phase 1 · Sponsor: University of Arkansas · Status: Not yet recruiting
Countries: United States
US states: Arkansas
NCT07437547
BPC 157 for Acute Hamstring Muscle Strain Repair
Phase: Phase 2 · Sponsor: Hudson Biotech · Status: Recruiting
Countries: China
US states: none listed
Bremelanotide
No open trials in the snapshot of .clinicaltrials.gov
CagriSema
Snapshot of .clinicaltrials.gov
NCT07817251
Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
Phase: Phase 3 · Sponsor: Novo Nordisk A/S · Status: Recruiting
Countries: United States
US states: Arizona, California, Connecticut, Florida, Hawaii, Illinois, Iowa, Kansas, Michigan, Nevada, New Mexico, North Carolina, Ohio, Tennessee, Texas, Utah, Virginia
NCT07745504
A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight
Phase: Phase 3 · Sponsor: Novo Nordisk A/S · Status: Recruiting
Countries: United States, Greece, Hungary, Portugal, Serbia, Sweden
US states: Georgia, Hawaii, Illinois, Indiana, Kentucky, North Carolina, South Carolina, Virginia
NCT07282613
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
Phase: Phase 3 · Sponsor: Novo Nordisk A/S · Status: Recruiting
Countries: United States, Argentina, Brazil, Colombia, India, Israel, Malaysia, Mexico, Taiwan, Thailand
US states: Connecticut, Florida, Georgia, Illinois, Indiana, Iowa, Michigan, New York, Pennsylvania, South Dakota, Tennessee, Texas, Virginia, Washington
NCT07564414
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
Phase: Phase 3 · Sponsor: Novo Nordisk A/S · Status: Recruiting
Countries: United States, Argentina, Australia, Austria, Belgium, Bulgaria, Canada, Czechia, France, Greece, Hungary, Italy, Netherlands, Poland, Portugal, Romania, Slovakia, South Africa, Spain
US states: Alabama, Arizona, Arkansas, California, Colorado, Florida, Georgia, Idaho, Illinois, Iowa, Kansas, Kentucky, Maryland, Michigan, Minnesota, Mississippi, Missouri, New York, North Carolina, North Dakota, Ohio, Oklahoma, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, Utah, Virginia, Wisconsin
NCT07597018
A Research Study to Compare Blood Levels of Cagrilintide After Multiple Doses of Different Versions of Cagrilintide in Adults With Overweight or Obesity
Phase: Phase 1 · Sponsor: Novo Nordisk A/S · Status: Recruiting
Countries: Germany
US states: none listed
NCT07527195
Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscle Health)
Phase: Phase 1 · Sponsor: Novo Nordisk A/S · Status: Recruiting
Countries: Denmark
US states: none listed
NCT07253285
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
Phase: Phase 3 · Sponsor: Novo Nordisk A/S · Status: Recruiting
Countries: United States, Australia, Austria, Belgium, Bulgaria, China, Colombia, Croatia, Denmark, Hungary, India, Israel, Italy, Malaysia, Mexico, Netherlands, Poland, Portugal, Romania, Serbia, Slovakia, Spain, Sweden, Taiwan, Thailand, United Kingdom
US states: California, Florida, Georgia, Idaho, Indiana, Kansas, Louisiana, Maryland, Minnesota, New York, North Dakota, Ohio, Oklahoma, Pennsylvania, South Carolina, South Dakota, Tennessee, Texas, Utah
NCT07010432
The Role of the Amylin Analogue Cagrilintide in Bone Metabolism
Phase: Phase 1 · Sponsor: Novo Nordisk A/S · Status: Recruiting
Countries: Denmark
US states: none listed
Cerebrolysin
Snapshot of .clinicaltrials.gov
NCT07846488
Combined Acupuncture-Based Therapy for Rehabilitation After Ischemic Stroke
Phase: Not applicable · Sponsor: National Hospital of Acupuncture, Vietnam · Status: Not yet recruiting
Countries: Vietnam
US states: none listed
NCT06339411
Cerebrolysin After Reperfusion in Extended-window EndoVascular Thrombectomy
Phase: Phase 2 · Sponsor: Chang Gung Memorial Hospital · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT06899464
Safety and Feasibility of Using Cerebrolysin in the Treatment of Primary Intracerebral Hemorrhage - a Prospective Randomized Open Blinded End-point Trial
Phase: Phase 4 · Sponsor: Cardinal Stefan Wyszynski University · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT07043686
Cerebrolysin in Early Stroke Rehabilitation - Tertiary Study
Phase: Not applicable · Sponsor: University Medical Centre Ljubljana · Status: Recruiting
Countries: Slovenia
US states: none listed
NCT06897176
Effects of Cerebrolysin on Language Ability in Non-fluent Aphasia Patients After Stroke: A Randomized, Placebo-controlled, Double-blinded, Single Center Study
Phase: Phase 4 · Sponsor: Yonsei University · Status: Recruiting
Countries: South Korea
US states: none listed
NCT05821075
Efficacy of Prednisolone Versus Cerebrolysin in the Treatment of Bell's Palsy
Phase: Phase 1/Phase 2 · Sponsor: October 6 University · Status: Recruiting
Countries: Egypt
US states: none listed
NCT04427241
Efficacy and Safety of Cerebrolysin on Prolonged Disorders of Consciousness
Phase: Phase 4 · Sponsor: Konkuk University Medical Center · Status: Recruiting
Countries: South Korea
US states: none listed
Dihexa
No open trials in the snapshot of .clinicaltrials.gov
DSIP
No open trials in the snapshot of .clinicaltrials.gov
Epitalon
No open trials in the snapshot of .clinicaltrials.gov
Finasteride
Snapshot of .clinicaltrials.gov
NCT07742553
Testosterone Therapy With or Without Finasteride After Spinal Cord Injury: TRT-SCI Trial
Phase: Phase 2/Phase 3 · Sponsor: VA Office of Research and Development · Status: Not yet recruiting
Countries: United States
US states: Colorado, Florida, New York
NCT07870759
Efficacy and Safety of Combination Therapy Compared With Monotherapy in Patients With Benign Prostatic Hyperplasia
Phase: Phase 3 · Sponsor: Il-Yang Pharm. Co., Ltd. · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT07731802
Finasteride and Cutibacterium
Phase: Phase 4 · Sponsor: University of Washington · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT07435012
Androgenic Alopecia TH07 Clinical Trial
Phase: Phase 3 · Sponsor: Triple Hair Inc · Status: Recruiting
Countries: Canada
US states: none listed
NCT06944145
New Treatment Strategies and Epigenetic Biomarker for Management of Benign Prostatic Hyperplasia
Phase: Phase 2 · Sponsor: Beth Israel Deaconess Medical Center · Status: Recruiting
Countries: United States
US states: Massachusetts
NCT06826001
Various Procedural Treatment Options for Androgenetic Alopecia
Phase: Phase 2 · Sponsor: Sheikh Zayed Medical College · Status: Not yet recruiting
Countries: Pakistan
US states: none listed
NCT04594018
Efficacy and Safety of Finlândia Hair Lotion Association on Androgenetic Alopecia
Phase: Phase 3 · Sponsor: EMS · Status: Recruiting
Countries: Brazil
US states: none listed
NCT06001619
Prostate Medication, Metabolism and Gut Microbiota
Phase: Phase 4 · Sponsor: Turku University Hospital · Status: Recruiting
Countries: Finland
US states: none listed
NCT04288427
5-Alpha Reductase 2 as a Marker of Resistance to 5ARI Therapy
Phase: Not applicable · Sponsor: Beth Israel Deaconess Medical Center · Status: Recruiting
Countries: United States
US states: Massachusetts
NCT02703220
Sleep Apnea in Elderly
Phase: Phase 4 · Sponsor: VA Office of Research and Development · Status: Recruiting
Countries: United States
US states: Michigan
GHK-Cu
Snapshot of .clinicaltrials.gov
NCT07437586
Topical GHK-Cu Gel for Acute Skin Wound Healing
Phase: Phase 2 · Sponsor: Hudson Biotech · Status: Recruiting
Countries: China
US states: none listed
GHRP-2
No open trials in the snapshot of .clinicaltrials.gov
GHRP-6
No open trials in the snapshot of .clinicaltrials.gov
Glutathione
Snapshot of .clinicaltrials.gov
NCT06340633
SPI-1005 in Adults Receiving Cochlear Implant
Phase: Phase 2 · Sponsor: Sound Pharmaceuticals, Incorporated · Status: Recruiting
Countries: United States
US states: Iowa, Ohio, Pennsylvania, South Carolina, Texas, Wisconsin
NCT07833865
The Effect of Light Therapy on Cellular Energy and Oxidative Stress in Healthy Adults and Type 1 Diabetic Patients
Phase: Not applicable · Sponsor: University of Thi-Qar · Status: Not yet recruiting
Countries: Iraq
US states: none listed
NCT06260566
Tolerability of Enteral NAC in Infants
Phase: Phase 1 · Sponsor: Sanjiv Harpavat · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT07543458
Therapeutics for Moderate and Severe Dengue
Phase: Phase 3 · Sponsor: Oxford University Clinical Research Unit, Vietnam · Status: Not yet recruiting
Countries: Bangladesh, Brazil, Colombia, Indonesia, Malaysia, Nepal, Peru, Philippines, Thailand, Vietnam
US states: none listed
NCT07792369
26DT052; Scaling Busulfan Dose to Body Surface Area in Children
Phase: Phase 1 · Sponsor: Children's Hospital of Philadelphia · Status: Not yet recruiting
Countries: United States
US states: Pennsylvania
NCT07856381
Understanding Lifespan Trajectories of Social Cognition, Brain Microstructure and Iron Dysregulation in Schizophrenia
Phase: Not stated · Sponsor: Medical University Innsbruck · Status: Recruiting
Countries: Austria
US states: none listed
NCT07690124
S-Acetyl Glutathione and Performance Recovery in Soccer
Phase: Not applicable · Sponsor: University of Thessaly · Status: Not yet recruiting
Countries: Greece
US states: none listed
NCT07622316
GAIP ASD Research Study
Phase: Phase 1 · Sponsor: Greater Atlanta Integrative Pediatrics · Status: Recruiting
Countries: United States
US states: Georgia
NCT07572890
Adia Med of Winter Park LLC Chronic Kidney Disease Research Study
Phase: Phase 1 · Sponsor: Adia Med of Winter Park LLC · Status: Recruiting
Countries: United States
US states: Florida
NCT07304440
Adia Med of Winter Park LLC Autism Spectrum Disorder Research Study
Phase: Phase 1 · Sponsor: Adia Med of Winter Park LLC · Status: Recruiting
Countries: United States
US states: Florida, Wisconsin
NCT07050173
Monitoring Patients With Repetitive Head Impact With Gamma-glutamylcysteine Supplementation
Phase: Phase 1 · Sponsor: Pravat Mandal · Status: Recruiting
Countries: United States
US states: Pennsylvania
NCT07064005
Enrichment of Glutathione Using Gamma-glutamylcysteine Supplementation in Parkinson's Disease Patients.
Phase: Phase 1 · Sponsor: Pravat Mandal · Status: Recruiting
Countries: United States
US states: Pennsylvania
NCT07448415
Evaluation of the Efficacy of Oral Tranexamic Acid and Glutathione-assisted Microneedling in Treatment of Melasma
Phase: Phase 2/Phase 3 · Sponsor: Assiut University · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT07379216
Efficacy Evaluation Study of Vitamin C and Glutathione Liquid Sachet
Phase: Not applicable · Sponsor: TCI Co., Ltd. · Status: Recruiting
Countries: Taiwan
US states: none listed
NCT07634991
To Evaluate the Efficacy and Safety of N-acetyl Cysteine Administration in Patients With Diabetic Retinopathy
Phase: Phase 4 · Sponsor: Ain Shams University · Status: Recruiting
Countries: Egypt
US states: none listed
NCT07314359
Rapid Effects of a Biofield Patch on Antioxidant Status and Cellular Energy
Phase: Not applicable · Sponsor: Natural Immune Systems Inc · Status: Recruiting
Countries: United States
US states: Oregon
NCT07595705
Gingival Hyperpigmentation Treatment
Phase: Phase 2 · Sponsor: Cairo University · Status: Recruiting
Countries: Egypt
US states: none listed
NCT06922669
Glucocorticoids for Acute Drug Induced Liver Injury With Hyperbilirubinemia
Phase: Not applicable · Sponsor: General Hospital of Shenyang Military Region · Status: Recruiting
Countries: China
US states: none listed
NCT06896422
Randomized Trial of Glutathione With Anti-PD-1 and Chemotherapy in Advanced NSCLC
Phase: Phase 1 · Sponsor: The First Affiliated Hospital of Zhengzhou University · Status: Recruiting
Countries: China
US states: none listed
NCT06213857
Beneficial Effect of Silymarin in Ulcerative Colitis
Phase: Phase 2 · Sponsor: Tanta University · Status: Recruiting
Countries: Egypt
US states: none listed
NCT06957808
Investigating the Effect of Diroximel Fumarate on Glutathione in Schizophrenia
Phase: Not applicable · Sponsor: King's College London · Status: Recruiting
Countries: United Kingdom
US states: none listed
NCT07202156
Ultrasound-Enhanced Delivery of Compound TXA Solution in Melasma
Phase: Not applicable · Sponsor: The First Affiliated Hospital with Nanjing Medical University · Status: Recruiting
Countries: China
US states: none listed
NCT06554392
Identification of Serum Level of Glutathione Peroxidase 4
Phase: Not stated · Sponsor: Assiut University · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT06620523
Prevent Cardiac Surgery Associated AKI Trial
Phase: Phase 2 · Sponsor: George Washington University · Status: Recruiting
Countries: United States
US states: District of Columbia
NCT06354712
Efficacy of N-acetylcysteine in Preventing Radiotherapy-Induced Oral Mucositis in Head and Neck Cancer Patients.
Phase: Phase 2 · Sponsor: Mansoura University · Status: Recruiting
Countries: Egypt
US states: none listed
NCT05241262
Study of N-acetylcysteine in the Treatment of Patients With the m.3243A>G Mutation and Low Brain Glutathione Levels
Phase: Phase 1 · Sponsor: Michio Hirano, MD · Status: Recruiting
Countries: United States
US states: New York
NCT05654922
Study to Evaluate ARINA-1 in the Prevention of Bronchiolitis Obliterans Progression in Participants With Bilateral Lung Transplant
Phase: Phase 3 · Sponsor: Renovion, Inc. · Status: Recruiting
Countries: United States
US states: Arizona, California, Florida, Illinois, Iowa, Maryland, Minnesota, Missouri, New York, Ohio, Pennsylvania, South Carolina, Tennessee, Texas, Virginia
NCT05689645
F573 for Injection for the Treatment of Liver Injury/Failure
Phase: Phase 2 · Sponsor: Beijing Continent Pharmaceutical Co, Ltd. · Status: Recruiting
Countries: China
US states: none listed
NCT05266417
Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's Disease
Phase: Phase 2 · Sponsor: Gateway Institute for Brain Research · Status: Recruiting
Countries: United States
US states: Florida
KPV
No open trials in the snapshot of .clinicaltrials.gov
Liraglutide
Snapshot of .clinicaltrials.gov
NCT07787936
GLP-1/GIP Receptor Agonists in Obesity-Related HFpEF: The GLIDE-HF Registry
Phase: Not stated · Sponsor: Miedziowe Centrum Zdrowia SA · Status: Not yet recruiting
Countries: Poland
US states: none listed
NCT07027969
Metabolic Surgery for Atrial Fibrillation Elimination
Phase: Phase 4 · Sponsor: Ali Aminian · Status: Not yet recruiting
Countries: United States
US states: Ohio
NCT07881783
A Real-world Study of Treatment Retention and Adherence to Secukinumab in Patients With Plaque Psoriasis (PsO) With or Without Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) Co-therapy
Phase: Not stated · Sponsor: Novartis Pharmaceuticals · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT07702461
Determination of Resistance Training Status for Patients on Glucagon-Like Peptide-1 Receptor Agonists
Phase: Not stated · Sponsor: Ohio State University · Status: Recruiting
Countries: United States
US states: Ohio
NCT06726577
TP04HN106 in the Treatment of Patients With Amyotrophic Lateral Sclerosis
Phase: Phase 1/Phase 2 · Sponsor: Talengen Institute of Life Sciences, Shenzhen, P.R. China. · Status: Recruiting
Countries: China
US states: none listed
NCT07301437
RWS of of Liraglutide Alone and in Combination With Orlistat for Weight Loss in Overweight/Obese Patients.
Phase: Phase 4 · Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT07107334
A Study to Estimate Early Clinical Efficacy Signals of GLP-1 Agonist Administration in Conjunction With Levonorgestrel Intrauterine Device in Obese Patients With Endometrioid Intraepithelial Neoplasia
Phase: Phase 2 · Sponsor: University of Florida · Status: Recruiting
Countries: United States
US states: Florida
NCT06836284
The Evira Study: Additional Support During Obesity Treatment
Phase: Not applicable · Sponsor: Karolinska Institutet · Status: Recruiting
Countries: Sweden
US states: none listed
NCT07225816
Examination of How the Duration of Fasting and Temporary Stopping of GLP-1 Medications Affect the Amount of Food Left in the Stomach in People Using Liraglutide (Injected), Semaglutide (Taken by Mouth) or Semaglutide (Injected)
Phase: Phase 1 · Sponsor: Novo Nordisk A/S · Status: Recruiting
Countries: United States
US states: California
NCT06976619
The Effect of Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in People With Type 1 and Type 2 Diabetes
Phase: Phase 2 · Sponsor: Mayo Clinic · Status: Recruiting
Countries: United States
US states: Minnesota
NCT06903923
Bone Metabolism in 12-21 Year Olds Undergoing Glucagon Like Peptide (GLP)-1 Receptor Agonist Therapy
Phase: Phase 2 · Sponsor: University of Virginia · Status: Recruiting
Countries: United States
US states: Virginia
NCT07042672
Behavioral Therapy and GLP-1 Analogue Effects on Binge Eating, Weight, and Coping in Obesity
Phase: Not stated · Sponsor: Haukeland University Hospital · Status: Recruiting
Countries: Norway
US states: none listed
NCT07094568
Tirzepatide vs Liraglutide in Bone
Phase: Not stated · Sponsor: National and Kapodistrian University of Athens · Status: Recruiting
Countries: Greece
US states: none listed
NCT06742710
Liraglutide Treatment in Obese Infertile PCOS Women
Phase: Phase 4 · Sponsor: Peking University Third Hospital · Status: Recruiting
Countries: China
US states: none listed
NCT07029009
Liraglutide Treatment in Patients With Maturity-onset Diabetes of the Young (MODY)
Phase: Phase 2 · Sponsor: Mansa · Status: Recruiting
Countries: United States
US states: Ohio
NCT06865365
Preoperative Use of Liraglutide Additionally to Common Dietological Measures as Opposed to Dietological Measures Alone
Phase: Phase 4 · Sponsor: Medical University of Vienna · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT07244003
Efficacy and Safety of the Met+SGLT-2i+GLP-1RA in Patients With Type 2 Diabetes With Poor Glycemic Control
Phase: Phase 4 · Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. · Status: Recruiting
Countries: China
US states: none listed
NCT06361238
Liraglutide in Preventing Delirium in Diabetic Elderly After Cardiac Surgery
Phase: Phase 3 · Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School · Status: Recruiting
Countries: China
US states: none listed
NCT06374875
Fibrosis Lessens After Metabolic Surgery
Phase: Phase 4 · Sponsor: The Cleveland Clinic · Status: Recruiting
Countries: United States, Brazil, Canada, Finland, India, Ireland, Italy, Kuwait, Mexico, Spain, Sweden, Switzerland, United Kingdom
US states: Arizona, Indiana, Minnesota, Ohio
NCT06686134
Comprehensive Clinical Evaluation Study of GLP-1RA
Phase: Not stated · Sponsor: LI YAN · Status: Recruiting
Countries: China
US states: none listed
NCT06720246
Impact of Bariatric Surgery and Liraglutide on Cognitive-Behavioral Markers of Long-Term Weight Loss in Obesity
Phase: Not stated · Sponsor: I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio · Status: Recruiting
Countries: Italy
US states: none listed
NCT07309094
Clinical, Morphometric and Biochemical Effects on Adiposopathy Associated With the Use of GLP-1RA in CKD
Phase: Not stated · Sponsor: Cardenal Herrera University · Status: Recruiting
Countries: Spain
US states: none listed
NCT05925959
Preoperative Weight Loss for Open Abdominal Wall Reconstruction
Phase: Not applicable · Sponsor: Benjamin T. Miller · Status: Recruiting
Countries: United States
US states: Illinois, Ohio
NCT05681299
Effects of GH and Lirglutide on AgRP
Phase: Phase 4 · Sponsor: Columbia University · Status: Recruiting
Countries: United States
US states: New York
NCT05268237
Safety, Tolerability and Preliminary Efficacy of Sublingual Liraglutide in Patients With Type 2 Diabetes Mellitus
Phase: Phase 1/Phase 2 · Sponsor: Biolingus · Status: Recruiting
Countries: Hong Kong
US states: none listed
NCT05390892
PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes
Phase: Phase 4 · Sponsor: Brigham and Women's Hospital · Status: Recruiting
Countries: United States
US states: Alabama, Arizona, California, Florida, Georgia, Illinois, Iowa, Kansas, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Nebraska, New York, North Carolina, Ohio, Oregon, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, Virginia, Wisconsin
NCT04575844
Effects of Exercise and GLP-1 Agonism on Muscle Microvascular Perfusion and Insulin Action in Adults With Metabolic Syndrome
Phase: Phase 4 · Sponsor: University of Virginia · Status: Recruiting
Countries: United States
US states: Virginia
NCT03883412
Effect of Exercise and/or Liraglutide on Vascular Dysfunction and Insulin Sensitivity in Type 2 Diabetes ( ZQL007)
Phase: Phase 4 · Sponsor: University of Virginia · Status: Recruiting
Countries: United States
US states: Virginia
NCT03087032
Liraglutide-bolus vs Glargine-bolus Therapy in Overweight/Obese Type 2 Diabetes Patients (LiraGooD)
Phase: Phase 4 · Sponsor: The First Affiliated Hospital of Xiamen University · Status: Recruiting
Countries: China
US states: none listed
NCT03878706
The Cardiovascular Effect of GLP-1 Agonist, SGLT2 Inhibitor and Their Combination
Phase: Not stated · Sponsor: University of Athens · Status: Recruiting
Countries: Greece
US states: none listed
LL-37
No open trials in the snapshot of .clinicaltrials.gov
Melanotan II
Snapshot of .clinicaltrials.gov
NCT07437560
Melanotan II (MT-II) as an Adjunct to NB-UVB Phototherapy for Repigmentation in Stable Nonsegmental Vitiligo
Phase: Phase 2 · Sponsor: Hudson Biotech · Status: Recruiting
Countries: China
US states: none listed
Melatonin
Snapshot of .clinicaltrials.gov
NCT07418554
Sleep Disturbances in Children and Adolescents With Post-traumatic Stress Disorder (PTSD): a Randomized Double-blind Placebo-controlled Trial to Investigate the Efficacy of Pediatric Prolonged-release Melatonin
Phase: Phase 3 · Sponsor: University Hospital, Strasbourg, France · Status: Not yet recruiting
Countries: France
US states: none listed
NCT07334197
Effect of Melatonin on Left Ventricular Reverse Remodeling and Inflammation in Peripartum Cardiomyopathy
Phase: Not applicable · Sponsor: Tanta University · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT07842900
Oral Melatonin as Adjunctive Therapy in Adults With Atopic Dermatitis
Phase: Not applicable · Sponsor: Can Tho University of Medicine and Pharmacy · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT07651514
The Effect of a Daily Magnesium and Melatonin Supplement on Sleep Quality in People With Nighttime Leg Cramps
Phase: Not applicable · Sponsor: StudySetGo · Status: Recruiting
Countries: United States
US states: Alabama, Arkansas, Florida, Georgia, North Carolina, South Carolina, Tennessee
NCT07863232
Melatonin and Immunonutrition for Pain Relief in Fibromyalgia
Phase: Not applicable · Sponsor: University of Thessaly · Status: Recruiting
Countries: Greece
US states: none listed
NCT07813936
Locally Delivered Melatonin Gel in Management of Stage II Grade B Periodontitis
Phase: Not applicable · Sponsor: Alexandria University · Status: Not yet recruiting
Countries: Egypt
US states: none listed
NCT07691996
Effects of Melatonin on Sleep Architecture of Critically Ill Patients in the ICU
Phase: Phase 4 · Sponsor: Rutgers, The State University of New Jersey · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT07576764
Pediatric Prolonged-Release Melatonin for Sleep Disturbances in Children and Adolescents With Anorexia Nervosa (MELSom-ANOREXIA)
Phase: Phase 3 · Sponsor: Assistance Publique Hopitaux De Marseille · Status: Not yet recruiting
Countries: France
US states: none listed
NCT07732725
Comparison Between the Effect of Two Different Doses of Oral Melatonin on Sleep Quality After Total Hip Arthroplasty
Phase: Early phase 1 · Sponsor: Benha University · Status: Not yet recruiting
Countries: Egypt
US states: none listed
NCT07695246
Efficacy of CBT-I With Adjuvant Melatonin in Older Adults Chronic Insomnia
Phase: Not applicable · Sponsor: The University of Hong Kong · Status: Recruiting
Countries: Hong Kong
US states: none listed
NCT07721324
Effect of Melatonin Administration on Systemic Lupus Erythematosus Patients
Phase: Phase 2/Phase 3 · Sponsor: Ain Shams University · Status: Not yet recruiting
Countries: Egypt
US states: none listed
NCT06489327
Comparing Two Doses of Oral Melatonin as Premedication in Children Undergoing Surgery
Phase: Not applicable · Sponsor: Al-Azhar University · Status: Recruiting
Countries: Egypt, Iraq
US states: none listed
NCT07652801
COMPARISON OF OUTCOME OF HYPOXIC ISCHEMIC ENCEPHLOPATHY MANAGED WITH COMBINATION OF MAGNESIUM SULPHATE AND MELATONIN VERSUS MAGNESIUM SULPHATE ALONE
Phase: Phase 3 · Sponsor: University of Child Health Sciences and Children's Hospital, Lahore · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT07221968
Melatonin for the Treatment of DEE-SWAS
Phase: Phase 2 · Sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc. · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT07336277
Sleep Quality and the Efficacy of a Multimodal Sleep Pathway in Hospitalized Orthopedic Trauma Patients
Phase: Phase 3 · Sponsor: Emory University · Status: Recruiting
Countries: United States
US states: Georgia
NCT07472075
Melatonin Versus Placebo for Bipolar Disorder
Phase: Phase 2 · Sponsor: Lars Vedel Kessing · Status: Recruiting
Countries: Denmark
US states: none listed
NCT07617922
Melatonin and Solifenacin for Double-J Ureteral Stent Symptoms
Phase: Phase 2 · Sponsor: Beni-Suef University · Status: Recruiting
Countries: Egypt
US states: none listed
NCT07553143
Effect of Preoperative Melatonin on Quality of Recovery After Elective Laparoscopic Cholecystectomy
Phase: Not applicable · Sponsor: Armed Forces Medical Institute Bangladesh · Status: Recruiting
Countries: Bangladesh
US states: none listed
NCT07542756
A SMART Approach to Evaluating the Benefits of Common Prescription and OTC Medications for Insomnia
Phase: Phase 4 · Sponsor: University of Pennsylvania · Status: Recruiting
Countries: United States
US states: Pennsylvania
NCT07503600
The Effect of Adjunctive Melatonin With Colistin in Patients With Multidrug-Resistant Gram-Negative Bacterial Infections
Phase: Phase 3 · Sponsor: Ain Shams University · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT07495605
Effect of 1% Melatonin Gel Versus Calcium Hydroxide as an Intracanal Medicament on the Intensity of Postoperative Pain, Bacterial Load Reduction and Periapical MMP-9 Levels in Patients With Necrotic Pulp.
Phase: Not applicable · Sponsor: Cairo University · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT07336095
Melatonin vs Midazolam in Children Undergoing Tonsillectomy
Phase: Phase 3 · Sponsor: Ain Shams University · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT07369284
Melatonin for Glycemic Control in Gestational Diabetes Mellitus
Phase: Phase 2 · Sponsor: Obstetrics & Gynecology Hospital of Fudan University · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT07120880
Efficacy of Chronotherapeutic Combination for Major Depressive Episode With Insomnia
Phase: Phase 3 · Sponsor: Assistance Publique - Hôpitaux de Paris · Status: Recruiting
Countries: France
US states: none listed
NCT07344467
Oral Melatonin Versus Oral Pregabalin on Postoperative Pain and Anxiety Following Spine Surgery
Phase: Not applicable · Sponsor: Tanta University · Status: Recruiting
Countries: Egypt
US states: none listed
NCT07375342
Melatonin for Post Tonsillectomy Emergence Agitation in Pediatric
Phase: Not applicable · Sponsor: Benha University · Status: Recruiting
Countries: Egypt
US states: none listed
NCT07869030
Melatonin Effect on Immediate Dental Implants in the Posterior Mandible
Phase: Not applicable · Sponsor: Future University in Egypt · Status: Recruiting
Countries: Egypt
US states: none listed
NCT07554716
Chronobiology and Enteral Nutrition
Phase: Not applicable · Sponsor: Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud · Status: Recruiting
Countries: Spain
US states: none listed
NCT07096635
Oral Melatonin With Intra Articular Analgesia on Pain After Arthroscopic Anterior Cruciate Ligament Reconstruction
Phase: Not applicable · Sponsor: Assiut University · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT07036367
The Use of Sublingual Melatonin Premedication in Geriatric Cataract Surgery
Phase: Phase 4 · Sponsor: Al-Azhar University · Status: Recruiting
Countries: Egypt, Iraq
US states: none listed
NCT07046429
Affect of Melatonin on Sleep and Cognition in Cirrhosis
Phase: Not applicable · Sponsor: Weill Medical College of Cornell University · Status: Recruiting
Countries: United States
US states: New York
NCT07036796
Effect of Melatonin in Patients With Diabetic Peripheral Neuropathy
Phase: Phase 2 · Sponsor: Ain Shams University · Status: Recruiting
Countries: Egypt
US states: none listed
NCT07067307
Melatonin in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
Phase: Phase 1/Phase 2 · Sponsor: Mansoura University · Status: Not yet recruiting
Countries: Egypt
US states: none listed
NCT06802913
A Novel Inhaled Formulation of Melatonin to Treat Adults With Insomnia: Efficacy Study
Phase: Early phase 1 · Sponsor: Woolcock Institute of Medical Research · Status: Recruiting
Countries: Australia
US states: none listed
NCT07345715
Oral Melatonin Versus Nebulized Dexmedetomidine on Emergence Agitation in Children Undergoing Adenotonsillectomy
Phase: Not applicable · Sponsor: Tanta University · Status: Recruiting
Countries: Egypt
US states: none listed
NCT07850934
Effect of Melatonin on Pulmonary Hypertension in Full Term Neonates
Phase: Not applicable · Sponsor: Ain Shams University · Status: Recruiting
Countries: Egypt
US states: none listed
NCT07003243
Effectiveness of Topical Application of Melatonin On Bone Density and Implant Stability In Immediate Implantation
Phase: Phase 1 · Sponsor: University of Baghdad · Status: Not yet recruiting
Countries: Iraq
US states: none listed
NCT06826755
Melatonin Effects on Cardiovascular Disease Mechanisms in Midlife Women: A Randomized Clinical Trial
Phase: Not applicable · Sponsor: Mayo Clinic · Status: Recruiting
Countries: United States
US states: Minnesota
NCT06996171
Comparative Efficacy of Magnesium Supplement and Melatonin Congener in Young Adults With Primary Insomnia
Phase: Not applicable · Sponsor: CMH Kharian Medical College · Status: Recruiting
Countries: Pakistan
US states: none listed
NCT06949904
The Role of Melatonin as an Adjuvant Therapy in Childhood Pneumonia
Phase: Phase 1/Phase 2 · Sponsor: Mian Muhammad Hassan Ahmed · Status: Recruiting
Countries: Pakistan
US states: none listed
NCT06935292
Oral Melatonin VS Nebulized Dexmedetomidine Premedication on Attenuation of Hemodynamic Response to Direct Laryngoscopy and Tracheal Intubation in Hypertensive Patients
Phase: Phase 2/Phase 3 · Sponsor: Tanta University · Status: Not yet recruiting
Countries: Egypt
US states: none listed
NCT07737665
Efficacy of Melatonin Treatment on Sleep Quality Improvement in Inflammatory Bowel Disease Patients With Clinical Remission
Phase: Phase 4 · Sponsor: Mahidol University · Status: Recruiting
Countries: Thailand
US states: none listed
NCT07307677
Melatonin & Metformin on Clinical & Biochemical Parameters in Insulin Resistant PCOS Compared to Metformin
Phase: Not applicable · Sponsor: Mst.Sumyara Khatun · Status: Recruiting
Countries: Bangladesh
US states: none listed
NCT06768749
The Impact of Melatonin Lotion on Sleep and Mental Health
Phase: Not applicable · Sponsor: University of Redlands · Status: Recruiting
Countries: United States
US states: California
NCT06846086
Cardioprotective Effects of Melatonin in Patients With Cardiomyopathy
Phase: Phase 3 · Sponsor: Tanta University · Status: Recruiting
Countries: Egypt
US states: none listed
NCT06809751
Evaluating Efficacy and Safety of Oral Melatonin in Acute Central Serous Chorioretinopathy
Phase: Phase 2/Phase 3 · Sponsor: Mohsen Pourazizi · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT06777342
Effect of Preoperative Sleep Intervention on Postoperative Delirium in Adult Patients Undergoing Cardiac Surgery
Phase: Not applicable · Sponsor: Yan Fuxia · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT05541276
MELAtonin for Prevention of Postoperative Agitation and Emergence Delirium in Children
Phase: Phase 3 · Sponsor: Arash Afshari · Status: Recruiting
Countries: Denmark
US states: none listed
NCT06756828
Effects of 3-Month Melatonin Treatment on Regional Cerebellar Structure and Blood Biomarkers in Alzheimer's Disease Spectrum
Phase: Not applicable · Sponsor: Saint Vincent's Hospital, Korea · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT06768580
Effect of Oral Melatonin Versus Intraoperative Lidocaine Infusion on Incidence of Postoperative Delirium in Elderly Patients Undergoing Total Hip Arthroplasty
Phase: Not applicable · Sponsor: Tanta University · Status: Recruiting
Countries: Egypt
US states: none listed
Methylene blue
No open trials in the snapshot of .clinicaltrials.gov
Minoxidil
Snapshot of .clinicaltrials.gov
NCT07529977
Phase 3 Study to Evaluate the Efficacy and Safety of Oral Minoxidil (N1087) in Men With Androgenetic Alopecia.
Phase: Phase 3 · Sponsor: Eurofarma Laboratorios S.A. · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT07758400
A Study on the Efficacy and Safety of Microneedling for Male Androgenetic Alopecia
Phase: Not applicable · Sponsor: Cheng Zhou · Status: Not yet recruiting
Countries: China
US states: none listed
NCT07594678
Minoxidil With or Without Low-Level Red-Light Therapy for Improving Chemotherapy-Induced Alopecia in Breast Cancer Patients
Phase: Phase 2 · Sponsor: Ohio State University Comprehensive Cancer Center · Status: Not yet recruiting
Countries: United States
US states: Ohio
NCT07862374
Oral Minoxidil With or Without a Multifactorial Drinkable Nutraceutical in Female Pattern Hair Loss: a Retrospective Study
Phase: Not stated · Sponsor: Olistic Research Labs S.L. · Status: Not yet recruiting
Countries: Spain
US states: none listed
NCT07716748
For an Investigator-led Hair Study Comparing Between Healthy and Hair Loss Volunteers
Phase: Not stated · Sponsor: National Skin Centre · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT07548918
Comparative Study of Microneedling With Topical Minoxidil 5% ± NB-UVB in Stable Vitiligo"
Phase: Phase 2 · Sponsor: Sohag University · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT07536100
VENEZE Peptide Factor Hair Serum Compared With Topical 2% Minoxidil for Androgenetic Alopecia
Phase: Not applicable · Sponsor: Institute of Dermatology, Thailand · Status: Recruiting
Countries: Thailand
US states: none listed
NCT07435012
Androgenic Alopecia TH07 Clinical Trial
Phase: Phase 3 · Sponsor: Triple Hair Inc · Status: Recruiting
Countries: Canada
US states: none listed
NCT07518342
The Effect of Nanofat Injection on Androgenetic Alopecia
Phase: Phase 4 · Sponsor: Assiut University · Status: Not yet recruiting
Countries: Egypt
US states: none listed
NCT07264790
Assessment of Topical Minoxidil on Intraoperative Flap Perfusion and Cutaneous Flap Viability in Breast Recon
Phase: Phase 1 · Sponsor: Duke University · Status: Recruiting
Countries: United States
US states: North Carolina
NCT07459933
Topical Methotrexate vs Minoxidil for Localized Alopecia Areata
Phase: Phase 4 · Sponsor: Jinnah Postgraduate Medical Centre · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT07563036
JAK2 Expression in Androgenetic Alopecia Before and After Topical Minoxidil
Phase: Not applicable · Sponsor: Kasr El Aini Hospital · Status: Recruiting
Countries: Egypt
US states: none listed
NCT07370519
Topical Application of Lactobacillus Reuteri for Androgenetic Alopecia
Phase: Phase 2 · Sponsor: Shenzhen People's Hospital · Status: Recruiting
Countries: China
US states: none listed
NCT07502976
Topical 2-Deoxy-D-ribose Hydrogel Versus Minoxidil 5% Solution for Androgenetic Alopecia
Phase: Not applicable · Sponsor: Kasr El Aini Hospital · Status: Recruiting
Countries: Egypt
US states: none listed
NCT07248410
A Split-Scalp Study Evaluating the Efficacy and Safety of Fractional Laser Therapy With and Without Exosomes in the Treatment of Androgenetic Alopecia
Phase: Not applicable · Sponsor: Chang Gung Memorial Hospital · Status: Recruiting
Countries: Taiwan
US states: none listed
NCT07273799
Comparison of Outcomes Between Topical Minoxidil Versus Oral Minoxidil for the Treatment of Androgenetic Alopecia
Phase: Phase 3 · Sponsor: Sheikh Zayed Federal Postgraduate Medical Institute · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT07203599
A Study on the Treatment of Androgenetic Alopecia in Young Men With Umbilical Cord Mesenchymal Stem Cell Exosomes
Phase: Phase 1/Phase 2 · Sponsor: Shenzhen People's Hospital · Status: Recruiting
Countries: China
US states: none listed
NCT07056933
Effect of Minoxidil Solution Iontophoresis on Androgenic Alopecia
Phase: Not applicable · Sponsor: Cairo University · Status: Not yet recruiting
Countries: Egypt
US states: none listed
NCT07018349
Low Dose Oral Minoxdil in Androgenic Alopecia
Phase: Not applicable · Sponsor: Jinnah Postgraduate Medical Centre · Status: Not yet recruiting
Countries: Pakistan
US states: none listed
NCT07012486
Efficacy of Dihydroartemisinin for Treating Female Androgenetic Alopecia
Phase: Early phase 1 · Sponsor: Shanghai Zhongshan Hospital · Status: Recruiting
Countries: China
US states: none listed
NCT07080931
Efficacy and Safety of 5% Minoxidil Foam in Female Androgenetic Alopecia
Phase: Phase 3 · Sponsor: Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd. · Status: Recruiting
Countries: China
US states: none listed
NCT06826001
Various Procedural Treatment Options for Androgenetic Alopecia
Phase: Phase 2 · Sponsor: Sheikh Zayed Medical College · Status: Not yet recruiting
Countries: Pakistan
US states: none listed
NCT06501924
Clinical Study of DA-002 and DA-005 As a Treatment for Hair Loss
Phase: Phase 3 · Sponsor: Applied Biology, Inc. · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT05417308
Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast Cancer
Phase: Early phase 1 · Sponsor: Ohio State University Comprehensive Cancer Center · Status: Recruiting
Countries: United States
US states: Ohio
NCT04594018
Efficacy and Safety of Finlândia Hair Lotion Association on Androgenetic Alopecia
Phase: Phase 3 · Sponsor: EMS · Status: Recruiting
Countries: Brazil
US states: none listed
NCT04207931
Treatment Results for Patients With Central Centrifugal Cicatricial Alopecia (CCCA): a Multicenter Prospective Study
Phase: Phase 4 · Sponsor: Wake Forest University Health Sciences · Status: Recruiting
Countries: United States
US states: North Carolina
MK-677
Snapshot of .clinicaltrials.gov
NCT07754045
Evaluating the Efficacy and Safety of LUM-201 Plus Semaglutide Versus Semaglutide Plus Placebo in Older Obese Adults
Phase: Phase 2 · Sponsor: Lumos Pharma · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT07129759
Phase 3 Long Term Safety Extension Study of LUM-201 in Children With Growth Hormone Deficiency
Phase: Phase 3 · Sponsor: Lumos Pharma · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT06948214
Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency
Phase: Phase 3 · Sponsor: Lumos Pharma · Status: Recruiting
Countries: United States, Argentina, Australia, Chile, India, New Zealand, Thailand, United Kingdom
US states: Alabama, California, Colorado, District of Columbia, Florida, Georgia, Indiana, Iowa, Louisiana, Minnesota, Missouri, Nevada, New Jersey, New York, Ohio, Oklahoma, South Carolina, Texas, Virginia, Washington
MOTS-c
No open trials in the snapshot of .clinicaltrials.gov
NAD+
Snapshot of .clinicaltrials.gov
NCT07839130
PEDIatric Cardiac Dysfunction Treated With Injectable Nicotinamide Adenine Dinucleotide
Phase: Phase 2 · Sponsor: Beijing Children's Hospital · Status: Not yet recruiting
Countries: China
US states: none listed
NCT07692633
A Clinical Trial to Assess the Absorption, Safety, and Efficacy of an Oral Nicotinamide Adenine Dinucleotide (NAD+) Supplement in Healthy Adults
Phase: Not applicable · Sponsor: Reus Research · Status: Not yet recruiting
Countries: Canada
US states: none listed
NCT07328100
Efficacy and Safety of Coenzyme I for Injection on Vascular Aging.
Phase: Not applicable · Sponsor: Shanghai 10th People's Hospital · Status: Not yet recruiting
Countries: China
US states: none listed
NCT06966583
NAD+ Supplement（NMN）With Radioimmunotherapy in Advanced NSCLC
Phase: Phase 1 · Sponsor: Sichuan University · Status: Not yet recruiting
Countries: China
US states: none listed
NCT06558253
The Safety and Efficacy of Coenzyme I for Injection in Promoting Hematopoietic Recovery of Patients After sUCBT
Phase: Phase 1 · Sponsor: Anhui Provincial Hospital · Status: Recruiting
Countries: China
US states: none listed
NCT06919328
Absorption and Tolerability of Injectable Administration of Niagen®+, as Compared to NAD+
Phase: Not applicable · Sponsor: Nutraceuticals Research Institute · Status: Recruiting
Countries: United States
US states: Alabama
Ondansetron
Snapshot of .clinicaltrials.gov
NCT05784350
Preoperative Point of Care Ultrasound Guided Fluid Optimization and Intravenous Ondansetron to Prevent General Anesthesia-Induced Hypotension
Phase: Not applicable · Sponsor: Meir Medical Center · Status: Not yet recruiting
Countries: Israel
US states: none listed
NCT07891312
Amisulpride Injection for the Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Laparoscopic Surgery
Phase: Not applicable · Sponsor: Qianfoshan Hospital · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT07795060
Ondansetron to Prevent Oral Rehydration Failure in Children With Cholera
Phase: Phase 2 · Sponsor: Public Interest Science Center · Status: Not yet recruiting
Countries: Republic of the Congo
US states: none listed
NCT07588217
Ondansetron for the Prevention of Patient Self-Inflicted Lung Injury in Patients With ARDS - Pilot RCT
Phase: Phase 2/Phase 3 · Sponsor: Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal · Status: Not yet recruiting
Countries: Canada
US states: none listed
NCT07848984
Chinese Herbal Acupoint Application Combined With Triple Antiemetic Therapy for Prevention of Chemotherapy-Induced Nausea and Vomiting in Breast Cancer
Phase: Phase 2 · Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine · Status: Not yet recruiting
Countries: China
US states: none listed
NCT07793760
Dexamethasone Versus Ondansetron for Preventing Post-Spinal Hypotension in Preeclampsia
Phase: Phase 4 · Sponsor: Assiut University · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT07858149
Effects of Ondansetron Timing During Spinal Anesthesia for Urologic Surgery
Phase: Phase 4 · Sponsor: Istanbul University · Status: Not yet recruiting
Countries: Turkey (Türkiye)
US states: none listed
NCT07868861
A Study to Compare the Bioavailability of Ondansetron Following Nasal (NS003) and IV Administration in Healthy Adults
Phase: Phase 1 · Sponsor: Nasus Pharma · Status: Recruiting
Countries: Israel
US states: none listed
NCT07813975
Evaluating the Impact of Vitamin D Supplementation on Healing Bed Sores in ICU.
Phase: Not applicable · Sponsor: Maha Salah · Status: Recruiting
Countries: Egypt
US states: none listed
NCT07681076
Study to Assess Safety and Tolerability of KarXT With Administration of Antiemetics in Healthy Volunteers
Phase: Phase 4 · Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company · Status: Recruiting
Countries: United States
US states: California, Florida, Georgia
NCT07761312
Afentanil and Remifentanil for Anesthesia Quality and Recovery
Phase: Phase 4 · Sponsor: Qianfoshan Hospital · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT07638527
Time to First Rescue Antiemetic With Ondansetron Plus Metoclopramide Versus Dexamethasone Plus Metoclopramide for PONV Prophylaxis in Laparoscopic Cholecystectomy
Phase: Phase 4 · Sponsor: Faisalabad Medical University · Status: Recruiting
Countries: Pakistan
US states: none listed
NCT07777276
Sleep Quality - Comparing the Effect of Ondansetron or Dexamethasone Given as Routine Prophylaxis Intraoperatively to Prevent Post Operative Nausea and Vomiting (SCORPION)
Phase: Phase 4 · Sponsor: Telethon Kids Institute · Status: Not yet recruiting
Countries: Australia, Brazil
US states: none listed
NCT07662200
A Simplified Regimen to Prevent Nausea and Vomiting Using Netupitant/Palonosetron in Germ Cell Cancer Patients Receiving Chemotherapy
Phase: Early phase 1 · Sponsor: Ottawa Hospital Research Institute · Status: Not yet recruiting
Countries: Canada
US states: none listed
NCT07740577
Routine Antiemetic Prophylaxis for Nonfasted Parturients Undergoing Cesarean Sections Under Spinal Anesthesia
Phase: Phase 4 · Sponsor: Sanliurfa Education and Research Hospital · Status: Recruiting
Countries: Turkey (Türkiye)
US states: none listed
NCT07697625
A Clinical Trial of MK-4082 in Healthy Participants (MK-4082-005)
Phase: Phase 1 · Sponsor: Merck Sharp & Dohme LLC · Status: Recruiting
Countries: United States
US states: California
NCT07768124
Acupoint Application for Chemotherapy-Induced Nausea and Vomiting in Lung Cancer
Phase: Not applicable · Sponsor: Xiu Huang · Status: Recruiting
Countries: China
US states: none listed
NCT07639723
Aprepitant to Improve Same Day Discharge for TKA
Phase: Phase 4 · Sponsor: Endeavor Health · Status: Not yet recruiting
Countries: United States
US states: Illinois
NCT07643285
Feasibility and Safety of a Pediatric ERAS Protocol for Laparoscopic Appendectomy
Phase: Not applicable · Sponsor: Ahmet Burak Doğan, MD · Status: Recruiting
Countries: Turkey (Türkiye)
US states: none listed
NCT07632144
Ondansetron Versus Lidocaine for Preventing Pain on Propofol Injection.
Phase: Not applicable · Sponsor: Mongi Slim Hospital · Status: Not yet recruiting
Countries: Tunisia
US states: none listed
NCT07706348
Intraperitoneal Irrigation of Ondansteron in Combination With Lidocaine in Acute Postoperative Pain
Phase: Phase 1/Phase 2 · Sponsor: Assiut University · Status: Recruiting
Countries: Egypt
US states: none listed
NCT07558226
Multimodal Anesthesia in Robotic Laparoscopic Nephrectomy
Phase: Not applicable · Sponsor: Fundacio Puigvert · Status: Recruiting
Countries: Spain
US states: none listed
NCT07603596
Opioid-free Anesthesia and Postoperative Delirium
Phase: Phase 1 · Sponsor: Qianfoshan Hospital · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT07381634
The Safety and Efficacy of Ondansetron in Reducing Immune Checkpoint Inhibitor-Related Toxicities
Phase: Phase 2 · Sponsor: First Affiliated Hospital of Wenzhou Medical University · Status: Recruiting
Countries: China
US states: none listed
NCT07511491
Ondansetron Lozenge Versus Intravenous for Prevention of Shivering in Cesarean Section
Phase: Not applicable · Sponsor: Tanta University · Status: Recruiting
Countries: Egypt
US states: none listed
NCT07455955
Personalized Antiemetic Regimen According to Patients' Pharmacogenetic Profile
Phase: Phase 2 · Sponsor: Chinese University of Hong Kong · Status: Recruiting
Countries: Hong Kong
US states: none listed
NCT07489742
Ondansetron Lozenge Versus Intravenous for Prevention of Shivering in Tonsillectomy
Phase: Not applicable · Sponsor: Tanta University · Status: Recruiting
Countries: Egypt
US states: none listed
NCT07458295
The Efficacy and Safety of Liposomal Bupivacaine for Transversus Abdominis Plane Block in Relieving Postoperative Pain After Laparoscopic Surgery in Gynecologic Oncology
Phase: Not applicable · Sponsor: Beijing Tiantan Hospital · Status: Recruiting
Countries: China
US states: none listed
NCT07458282
The Efficacy and Safety of Liposomal Bupivacaine for Transversus Abdominis Plane Block in Relieving Postoperative Pain After Laparoscopic Surgery
Phase: Not applicable · Sponsor: Beijing Tiantan Hospital · Status: Recruiting
Countries: China
US states: none listed
NCT07458256
The Efficacy and Safety of Liposomal Bupivacaine in Relieving Postoperative Pain After Laparoscopic Surgery
Phase: Not applicable · Sponsor: Beijing Tiantan Hospital · Status: Recruiting
Countries: China
US states: none listed
NCT07442539
The Efficacy and Safety of Liposomal Bupivacaine in Relieving Postoperative Pain After Hemorrhoid Surgery
Phase: Not applicable · Sponsor: Beijing Tiantan Hospital · Status: Recruiting
Countries: China
US states: none listed
NCT07432711
The Efficacy and Safety of Liposomal Bupivacaine in Relieving Postoperative Pain After Video-assisted Thoracoscopic Surgery
Phase: Not applicable · Sponsor: Beijing Tiantan Hospital · Status: Recruiting
Countries: China
US states: none listed
NCT07441902
The Efficacy and Safety of Liposomal Bupivacaine for Rhomboid Intercostal Nerve Block in Relieving Postoperative Pain After Video-assisted Thoracoscopic Surgery
Phase: Not applicable · Sponsor: Beijing Tiantan Hospital · Status: Recruiting
Countries: China
US states: none listed
NCT07330999
Three Variants of the PENG Block With and Without Perineural Adjuvants in Older Adults
Phase: Not applicable · Sponsor: Poznan University of Medical Sciences · Status: Recruiting
Countries: Poland
US states: none listed
NCT07699276
Steroid Sparing Regimen With Olanzapine and Palonosetron for Emetic Prevention for High Dose Cisplatin
Phase: Phase 2 · Sponsor: Mahidol University · Status: Recruiting
Countries: Thailand
US states: none listed
NCT07377903
Post Operative Shivering Following Anesthesia
Phase: Not applicable · Sponsor: Sohag University · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT07607990
Effects of Rectal Indomethacin Suppository on Postoperative CRBD in Patients Undergoing LRP
Phase: Not applicable · Sponsor: Zhejiang University · Status: Recruiting
Countries: China
US states: none listed
NCT07361822
Comparison of Cumulative Opioid Consumption Between Variable-Rate Feedback Infusion and Fixed-Rate Basal Infusion Modes of Intravenous PCA Following Mixed Surgery
Phase: Not applicable · Sponsor: Beijing Tiantan Hospital · Status: Recruiting
Countries: China
US states: none listed
NCT07375121
Comparison of the Efficacy and Safety of Fixed-rate Basal Infusion Mode and Time-programmed Decremental Background Infusion Mode of Intravenous PCA Following Mixed Surgery
Phase: Not applicable · Sponsor: Beijing Tiantan Hospital · Status: Recruiting
Countries: China
US states: none listed
NCT07246070
Nano-crystalline Megestrol Acetate for Chemotherapy-induced Nausea and Vomiting
Phase: Phase 2 · Sponsor: AIPING ZHOU · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT06869967
Evaluation of Postoperative Pain Control in Ear Surgery
Phase: Not applicable · Sponsor: Kocaeli University · Status: Recruiting
Countries: Turkey (Türkiye)
US states: none listed
NCT06953570
Impact of Frailty on Nalbuphine Dose for Postoperative Analgesia in Elderly Patients Undergoing Laparoscopic GI Surgery
Phase: Not stated · Sponsor: Yongtao Sun · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT07164677
Serratus Posterior Superior Plane Block for Postoperative Pain in Cardiac Surgery
Phase: Not applicable · Sponsor: Ondokuz Mayıs University · Status: Recruiting
Countries: Turkey (Türkiye)
US states: none listed
NCT06952920
Electroacupuncture for Chemotherapy-Induced GI Symptom Clusters in Breast Cancer
Phase: Phase 3 · Sponsor: Jiuda Zhao · Status: Recruiting
Countries: China
US states: none listed
NCT07124195
Nanocrystalline Megestrol for Managing Chemotherapy-Induced Nausea and Vomiting
Phase: Phase 3 · Sponsor: The First Affiliated Hospital of Xinxiang Medical College · Status: Not yet recruiting
Countries: China
US states: none listed
NCT07088601
Efficacy of Oral Ondansetron Strips on Prevention of Post-Spinal Shivering
Phase: Phase 4 · Sponsor: Cairo University · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT06530563
the Efficacy and Safety of Oliceridine Fumarate Injection for Acute Pain After Abdominal Surgery
Phase: Phase 4 · Sponsor: Xiangya Hospital of Central South University · Status: Not yet recruiting
Countries: China
US states: none listed
NCT07084753
Non-opioid Anesthesia Based on Thoracic Paravertebral Block During Laparoscopic Sleeve Gastrectomy
Phase: Not applicable · Sponsor: IVO JURISIC · Status: Not yet recruiting
Countries: Croatia
US states: none listed
NCT06938581
ERAS Protocols in Breast Conserving Surgery
Phase: Not applicable · Sponsor: University of Nebraska · Status: Recruiting
Countries: United States
US states: Nebraska
NCT06904235
Study With IV NEPA (Fosnetupitant/Palonosetron) for the Prevention of Chemotherapy-induced Nausea and Vomiting in Paediatric Cancer Patients Undergoing Highly Emetogenic Chemotherapy (HEC)
Phase: Phase 2 · Sponsor: Helsinn Healthcare SA · Status: Recruiting
Countries: Greece, Poland, Romania, Turkey (Türkiye)
US states: none listed
Orforglipron
Snapshot of .clinicaltrials.gov
NCT07790861
A Study of Orforglipron (LY3502970) in Chinese Participants With Obesity or Overweight and Weight-Related Health Problems
Phase: Phase 3 · Sponsor: Eli Lilly and Company · Status: Not yet recruiting
Countries: China
US states: none listed
NCT07729332
Switching to Oral Weight Management Pharmacotherapy to Prevent Weight Regain After GLP-1 Therapy Discontinuation
Phase: Phase 4 · Sponsor: Massachusetts General Hospital · Status: Not yet recruiting
Countries: United States
US states: Massachusetts
NCT07739537
PATHS-T2D: A Recall-by-Genotype Study of Physiologic and Pharmacologic Responses
Phase: Phase 4 · Sponsor: Massachusetts General Hospital · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT07793019
IBI3042 Study in Healthy Participants and Overweight or Obese Participants
Phase: Phase 1 · Sponsor: Innovent Biologics (Suzhou) Co. Ltd. · Status: Recruiting
Countries: China
US states: none listed
NCT07794579
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Phase: Phase 3 · Sponsor: Eli Lilly and Company · Status: Recruiting
Countries: United States, Argentina, China, Czechia, Germany, India, Japan, Mexico, Puerto Rico, South Korea, Spain, Taiwan
US states: Alabama, Arizona, California, Connecticut, Florida, Georgia, Idaho, Illinois, Iowa, Kansas, Kentucky, Louisiana, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Nevada, New Jersey, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, Tennessee, Texas, Virginia, West Virginia
NCT07613307
A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes Who Observe Ramadan Fasting
Phase: Phase 3 · Sponsor: Eli Lilly and Company · Status: Recruiting
Countries: India, Saudi Arabia, South Africa, United Arab Emirates
US states: none listed
NCT07668336
A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes
Phase: Phase 3 · Sponsor: Eli Lilly and Company · Status: Recruiting
Countries: United States, Belgium, Brazil, India, Italy, Japan, Mexico, South Korea, Spain, Taiwan, United Kingdom
US states: California, Connecticut, Georgia, Idaho, Kansas, New York, Oklahoma, Pennsylvania, Tennessee, Texas
NCT07107334
A Study to Estimate Early Clinical Efficacy Signals of GLP-1 Agonist Administration in Conjunction With Levonorgestrel Intrauterine Device in Obese Patients With Endometrioid Intraepithelial Neoplasia
Phase: Phase 2 · Sponsor: University of Florida · Status: Recruiting
Countries: United States
US states: Florida
NCT07241390
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
Phase: Phase 3 · Sponsor: Eli Lilly and Company · Status: Recruiting
Countries: Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, China, Colombia, Czechia, Estonia, France, Germany, Greece, Hungary, India, Israel, Italy, Japan, Lithuania, Malaysia, Mexico, Netherlands, New Zealand, Philippines, Poland, Romania, Serbia, Slovakia, South Africa, South Korea, Spain, Taiwan, Thailand, Tunisia, Turkey (Türkiye), Ukraine, United Kingdom
US states: none listed
NCT07223593
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
Phase: Phase 3 · Sponsor: Eli Lilly and Company · Status: Recruiting
Countries: United States, Argentina, Australia, Brazil, Canada, China, France, Greece, India, Israel, Japan, Netherlands, Poland, Puerto Rico, Slovakia, South Korea, Taiwan, United Kingdom
US states: Alabama, Arizona, California, Colorado, Florida, Indiana, Maryland, Michigan, Pennsylvania, Tennessee, Texas, Utah, Virginia, Washington
NCT07202884
A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight
Phase: Phase 3 · Sponsor: Eli Lilly and Company · Status: Recruiting
Countries: United States, Canada, China, Czechia, India, Japan, Mexico, Poland, Romania, South Korea
US states: Alabama, Arizona, California, Colorado, Florida, Georgia, Michigan, Pennsylvania, Texas, Virginia, Washington
NCT06672939
A Study of Orforglipron (LY3502970) in Adolescent Participants With Obesity, or Overweight With Related Comorbidities
Phase: Phase 3 · Sponsor: Eli Lilly and Company · Status: Recruiting
Countries: United States, Israel, Italy, Japan, Poland, United Kingdom
US states: California, Connecticut, Georgia, Illinois, Louisiana, Missouri, North Carolina, Pennsylvania, Tennessee, Texas
NCT06672549
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Phase: Phase 3 · Sponsor: Eli Lilly and Company · Status: Recruiting
Countries: United States, Belgium, Brazil, China, Israel, Italy, Japan, Mexico, Poland, Portugal, South Korea, Spain, United Kingdom
US states: Arizona, California, Colorado, Connecticut, Florida, Georgia, Illinois, Indiana, Kentucky, Louisiana, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Nebraska, New York, North Carolina, Ohio, Oklahoma, Pennsylvania, South Carolina, Tennessee, Texas, Utah, Virginia, Washington
Oxytocin
Snapshot of .clinicaltrials.gov
NCT07730294
Evaluating Intranasal Oxytocin (TNX-1900) for Pain Relief and Recovery After Pituitary Surgery
Phase: Phase 2 · Sponsor: Yale University · Status: Not yet recruiting
Countries: United States
US states: Connecticut
NCT07815496
The Effects of Oxytocin on Fairness Perception and Related Prosocial Behaviors
Phase: Not applicable · Sponsor: University of Electronic Science and Technology of China · Status: Recruiting
Countries: China
US states: none listed
NCT06364228
Intranasal Oxytocin Intervention for Caregivers to Persons With Dementia
Phase: Phase 2 · Sponsor: University of Nebraska · Status: Recruiting
Countries: United States
US states: Nebraska
NCT07559656
Oxytocin's Effects on Real Time-fMRI Neurofeedback Training of Anterior Insula Activity
Phase: Not applicable · Sponsor: University of Electronic Science and Technology of China · Status: Recruiting
Countries: China
US states: none listed
NCT07425938
Oxytocin's Effects on Emotional Processing and Its Acting Routes
Phase: Not applicable · Sponsor: University of Electronic Science and Technology of China · Status: Recruiting
Countries: China
US states: none listed
NCT07367672
The Power of Belief: Expectation-driven and Placebo Modulation of Empathic Pain
Phase: Not applicable · Sponsor: University of Electronic Science and Technology of China · Status: Recruiting
Countries: China
US states: none listed
NCT07162584
Oxytocin and Human Defensive Responses in a Dynamic Situation
Phase: Not applicable · Sponsor: University of Electronic Science and Technology of China · Status: Recruiting
Countries: China
US states: none listed
NCT04789148
Effects of Intranasal Oxytocin in Patients With Arginine-vasopressin Deficiency
Phase: Phase 1 · Sponsor: Elizabeth Austen Lawson · Status: Recruiting
Countries: United States
US states: Massachusetts
NCT07265180
Oxytocin-Augmented Group Psychotherapy for Patients With Schizophrenia - an Oxytocin-dose Comparison
Phase: Not applicable · Sponsor: Charite University, Berlin, Germany · Status: Recruiting
Countries: Germany
US states: none listed
NCT06808516
Effects of Intranasal Oxytocin on Sexual Well-Being in Patients With Arginine Vasopressin Deficiency and Healthy Controls
Phase: Phase 2 · Sponsor: University Hospital, Basel, Switzerland · Status: Recruiting
Countries: Switzerland
US states: none listed
NCT06676774
Effect of Intranasal Oxytocin on Emotion Recognition and Acute Psycho-Social Stress-induced Cortisol Increase in Patients With Central Diabetes Insipidus and Healthy Controls
Phase: Phase 2 · Sponsor: University Hospital, Basel, Switzerland · Status: Recruiting
Countries: Switzerland
US states: none listed
NCT06194851
Examining Intranasal Oxytocin Augmentation of Brief Couples Therapy for Veterans With PTSD
Phase: Phase 2 · Sponsor: VA Office of Research and Development · Status: Recruiting
Countries: United States
US states: California
NCT06222749
Oxytocin and Reward Processing in Women
Phase: Not applicable · Sponsor: International Research Training Group 2804 · Status: Recruiting
Countries: Germany
US states: none listed
NCT06248710
Dog Presence and Oxytocin on Trust Towards Therapists
Phase: Phase 2/Phase 3 · Sponsor: Dr. Karin Hediger · Status: Recruiting
Countries: Switzerland
US states: none listed
NCT07551882
Oxytocin Plus Self-compassion Training in Borderline Personality Disorder
Phase: Phase 2 · Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau · Status: Recruiting
Countries: Spain
US states: none listed
NCT06036004
Oxytocin Substitution Therapy in Patients With Central Diabetes Insipidus
Phase: Phase 2 · Sponsor: University Hospital, Basel, Switzerland · Status: Recruiting
Countries: Germany, Netherlands, Switzerland
US states: none listed
NCT05761860
The Potential of Oxytocin to Reduce Opioid Abuse Liability and Pain Among Older Adults
Phase: Early phase 1 · Sponsor: University of Florida · Status: Recruiting
Countries: United States
US states: Florida
NCT05754073
Oxytocin Effects on Bone in Children With Autism Spectrum Disorder
Phase: Phase 2 · Sponsor: Elizabeth Austen Lawson · Status: Recruiting
Countries: United States
US states: Massachusetts, Virginia
NCT05864508
Interest of Oxytocin as an Adjuvant Treatment of Psycho-educational Measures in Challenging Behaviors in Children With Autism Spectrum Disorders and Moderate to Severe Intellectual Disability: Feasibility and Safety Study.
Phase: Phase 2 · Sponsor: University Hospital, Toulouse · Status: Not yet recruiting
Countries: France
US states: none listed
NCT05664516
A Study of the Effects of Oxytocin in Adults With Binge-eating Disorder
Phase: Phase 2 · Sponsor: Massachusetts General Hospital · Status: Recruiting
Countries: United States
US states: Massachusetts
NCT04218409
Opioid-Sparing and Pain-Reducing Properties of Syntocinon: A Dose-Effect Determination
Phase: Early phase 1 · Sponsor: University of Florida · Status: Recruiting
Countries: United States
US states: Florida
NCT03860233
Benefits of Oxytocin in Obstructive Sleep Apnea (OSA) Patients Using Continuous Positive Airway Pressure (CPAP) Machine
Phase: Phase 1 · Sponsor: Vivek Jain · Status: Recruiting
Countries: United States
US states: District of Columbia
PEG-MGF
No open trials in the snapshot of .clinicaltrials.gov
Retatrutide
Snapshot of .clinicaltrials.gov
NCT07467447
Effect of LY3437943 Versus Placebo in Participants Who Have Obesity or Are Overweight
Phase: Phase 2 · Sponsor: Hudson Biotech · Status: Recruiting
Countries: China
US states: none listed
NCT07165028
Withheld under our publishing rules. Read it in the official record.
Phase: Phase 3 · Sponsor: Eli Lilly and Company · Status: Recruiting
Countries: United States, Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, China, Czechia, France, Germany, Hong Kong, Hungary, India, Israel, Italy, Japan, Mexico, Netherlands, New Zealand, Norway, Poland, Portugal, Puerto Rico, Romania, South Korea, Spain, Sweden, Switzerland, Taiwan, Turkey (Türkiye), Ukraine, United Kingdom
US states: Alabama, Arizona, Arkansas, California, Colorado, Connecticut, Florida, Georgia, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Nevada, New Jersey, New Mexico, New York, North Carolina, Ohio, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, Utah, Virginia, Washington, West Virginia
Semaglutide
Snapshot of .clinicaltrials.gov
NCT07586150
Personalized Pharmaco-Lifestyle Interventions for Severe Mental Illnesses (LIFETRAIN)
Phase: Not applicable · Sponsor: Ludwig-Maximilians - University of Munich · Status: Not yet recruiting
Countries: Austria, Germany, Netherlands
US states: none listed
NCT07430332
GLP-1 RA for Stage 1 Type 1 Diabetes
Phase: Phase 2 · Sponsor: Children's Hospital Medical Center, Cincinnati · Status: Not yet recruiting
Countries: United States
US states: Ohio
NCT07797036
Postpartum Semaglutide to Reduce Cardiometabolic Risk After Gestational Diabetes Mellitus
Phase: Phase 2/Phase 3 · Sponsor: University of Massachusetts, Worcester · Status: Not yet recruiting
Countries: United States
US states: Massachusetts
NCT07711548
Can Two Dietary Interventions Maintain Weight Loss for 12 Months After GLP-1 Therapy in Adults With Overweight/Obesity?
Phase: Not applicable · Sponsor: Knut Mai · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT07754045
Evaluating the Efficacy and Safety of LUM-201 Plus Semaglutide Versus Semaglutide Plus Placebo in Older Obese Adults
Phase: Phase 2 · Sponsor: Lumos Pharma · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT07731256
Semaglutide for Low Back Pain
Phase: Phase 2 · Sponsor: Washington University School of Medicine · Status: Not yet recruiting
Countries: United States
US states: Alabama, Missouri
NCT05714683
Regulatory Post Marketing Surveillance (rPMS) Study of Rybelsus (Oral Semaglutide) to Evaluate Safety and Effectiveness in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in Korea
Phase: Not stated · Sponsor: Novo Nordisk A/S · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT07879612
Semaglutide for the Treatment of Cannabis Use Disorder
Phase: Phase 2 · Sponsor: Massachusetts General Hospital · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT07462663
SHAPE-ENDO: Pilot Randomized Trial of Multimodal Pre-Surgical Optimization Versus Standard Surgery in Patients With Obesity and Early-Stage Endometrial Cancer
Phase: Phase 4 · Sponsor: Hospital Universitari de Bellvitge · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT07614412
SHIELD-T1D: Shingrix and GLP-1 Agonist for Beta-Cell Preservation in Recent-Onset Type 1 Diabetes.
Phase: Phase 2 · Sponsor: Ministry of Health, Saudi Arabia · Status: Not yet recruiting
Countries: Saudi Arabia
US states: none listed
NCT07820358
Semaglutide, Weight Loss, and LNG-IUD for Conservative Treatment of Endometrial Atypical Hyperplasia and Grade 1 Endometrial Cancer
Phase: Phase 2 · Sponsor: The Methodist Hospital Research Institute · Status: Not yet recruiting
Countries: United States
US states: Texas
NCT07787936
GLP-1/GIP Receptor Agonists in Obesity-Related HFpEF: The GLIDE-HF Registry
Phase: Not stated · Sponsor: Miedziowe Centrum Zdrowia SA · Status: Not yet recruiting
Countries: Poland
US states: none listed
NCT07858331
Patient-centred Intervention With Virtual Support for Obesity and Kidney Transplant Access
Phase: Phase 4 · Sponsor: Kristin Clemens · Status: Not yet recruiting
Countries: Canada
US states: none listed
NCT07760948
HMB Plus Vitamin D to Preserve Muscle in Older Adults Starting Semaglutide
Phase: Phase 2 · Sponsor: Vanderbilt University Medical Center · Status: Not yet recruiting
Countries: United States
US states: Tennessee
NCT07770282
Efficacy and Safety of Semaglutide Versus Placebo on Cardiometabolic Profile in Patients With Schizophrenia With Metabolic Syndrome
Phase: Phase 3 · Sponsor: All India Institute of Medical Sciences, Bhubaneswar · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT06977438
GLP-1 Plus Lifestyle for Overall Wellness: Find Your Way Forward
Phase: Phase 4 · Sponsor: University of Minnesota · Status: Not yet recruiting
Countries: United States
US states: Minnesota
NCT07855900
SYNCHRONIZE®-START- A Study to Test Whether Survodutide Helps People Living With Overweight or Obesity Who do Not Have Diabetes to Lose Weight
Phase: Phase 3 · Sponsor: Boehringer Ingelheim · Status: Not yet recruiting
Countries: United States
US states: Florida
NCT07866066
Maridebart Cafraglutide Versus Semaglutide in Participants With Type 2 Diabetes
Phase: Phase 3 · Sponsor: Amgen · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT07249554
Combination Therapy for Alcohol Use Disorder
Phase: Phase 2 · Sponsor: Johns Hopkins University · Status: Not yet recruiting
Countries: United States
US states: Maryland
NCT07878494
Dietary, Medication, and Endoscopic Interventions for Post-Bariatric Hypoglycemia
Phase: Not applicable · Sponsor: Stanford University · Status: Not yet recruiting
Countries: United States
US states: California
NCT06546384
GLP-1 RA on Alcohol Consumption, Metabolism and Liver Parameters in Patients With Obesity and Fatty Liver Disease
Phase: Not applicable · Sponsor: Insel Gruppe AG, University Hospital Bern · Status: Not yet recruiting
Countries: Switzerland
US states: none listed
NCT07832084
Comparing Different Medication Regimens to Maintaining Weight Loss Among Adults With Obesity Using GLP-1s
Phase: Phase 4 · Sponsor: Jing Luo · Status: Not yet recruiting
Countries: United States
US states: Pennsylvania
NCT07027969
Metabolic Surgery for Atrial Fibrillation Elimination
Phase: Phase 4 · Sponsor: Ali Aminian · Status: Not yet recruiting
Countries: United States
US states: Ohio
NCT07845994
SEMAFORCRANIO : Multicenter, Double-blind, Parallel, Randomized Controlled Trial of the Efficacy of Semaglutide in Hypothalamic Obesity Secondary to Craniopharyngioma in Children Aged 12 to 17 Years
Phase: Phase 3 · Sponsor: University Hospital, Angers · Status: Not yet recruiting
Countries: France
US states: none listed
NCT07511543
Glucagon-like Peptide-1 Receptor Agonists for Endovascular Stroke Thrombectomy
Phase: Phase 2 · Sponsor: Population Health Research Institute · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT07881783
A Real-world Study of Treatment Retention and Adherence to Secukinumab in Patients With Plaque Psoriasis (PsO) With or Without Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) Co-therapy
Phase: Not stated · Sponsor: Novartis Pharmaceuticals · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT07840729
Evaluate the Safety and Tolerability of Multiple Doses of JMT206 Injection in Obese Participants
Phase: Phase 1 · Sponsor: Shanghai JMT-Bio Inc. · Status: Not yet recruiting
Countries: China
US states: none listed
NCT07874971
Short Term Effects of Semaglutide on Body Composition and Performance
Phase: Not applicable · Sponsor: Morten Hostrup, PhD · Status: Not yet recruiting
Countries: Denmark
US states: none listed
NCT07874932
Long-Term Effects of Semaglutide on Body Composition and Performance in Running
Phase: Not applicable · Sponsor: Morten Hostrup, PhD · Status: Not yet recruiting
Countries: Denmark
US states: none listed
NCT07891156
Lean Mass Changes With Semaglutide in Adults With Type 1 Diabetes and Overweight/Obesity.
Phase: Phase 2/Phase 3 · Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre · Status: Recruiting
Countries: Canada
US states: none listed
NCT07881770
Semaglutide Health Outcomes and Patient Adherence in Australia
Phase: Not stated · Sponsor: Novo Nordisk A/S · Status: Not yet recruiting
Countries: Australia
US states: none listed
NCT07812597
A Study Evaluating Safety and Tolerability of Switching From Semaglutide to Zovaglutide in Adults With Obesity (HORIZON-SWITCH-SZ)
Phase: Phase 2 · Sponsor: Beijing QL Biopharmaceutical Co.,Ltd · Status: Not yet recruiting
Countries: China
US states: none listed
NCT07627191
GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer
Phase: Early phase 1 · Sponsor: University of Arizona · Status: Recruiting
Countries: United States
US states: Arizona
NCT07855133
A Research Study Investigating How Adults With Overweight or Obesity, With or Without Type 2 Diabetes, Tolerate Switching to a New Treatment (Zenagamtide) From Their Current Semaglutide Medication
Phase: Phase 1 · Sponsor: Novo Nordisk A/S · Status: Recruiting
Countries: United States
US states: California, Maryland
NCT07816744
Danish Trial of Weight Loss to Reduce Atrial Fibrillation Progression
Phase: Not applicable · Sponsor: Axel Brandes · Status: Not yet recruiting
Countries: Denmark
US states: none listed
NCT07859137
Semaglutide Before Primary Metabolic and Bariatric Surgery in Patients With BMI 60 kg/m² or Higher
Phase: Phase 4 · Sponsor: General Committee of Teaching Hospitals and Institutes, Egypt · Status: Not yet recruiting
Countries: Egypt
US states: none listed
NCT07423481
Weight Trajectories and Predictive Factors After Semaglutide in Patients With Grade 3 and Complicated Obesity
Phase: Not stated · Sponsor: Nantes University Hospital · Status: Not yet recruiting
Countries: France
US states: none listed
NCT07859150
Semaglutide 2.4 mg Once Weekly for Recurrent Weight Gain After Metabolic and Bariatric Surgery (RESURGE)
Phase: Phase 4 · Sponsor: General Committee of Teaching Hospitals and Institutes, Egypt · Status: Not yet recruiting
Countries: Egypt
US states: none listed
NCT07872904
FutureShape Family
Phase: Phase 4 · Sponsor: Signe Torekov · Status: Not yet recruiting
Countries: Denmark
US states: none listed
NCT07859189
Immediate Versus Criterion-triggered Semaglutide for Suboptimal Clinical Response One Year After Primary Metabolic and Bariatric Surgery
Phase: Phase 4 · Sponsor: General Committee of Teaching Hospitals and Institutes, Egypt · Status: Not yet recruiting
Countries: Egypt
US states: none listed
NCT07389941
Semaglutide PrIor to CathEeter Ablation in Patients With Atrial Fibrillation
Phase: Phase 4 · Sponsor: University of Luebeck · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT07737522
Myocardial Metabolic Flux in Pulmonary Arterial Hypertension
Phase: Phase 2 · Sponsor: Imperial College London · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT07859176
Tapered Versus Abrupt Discontinuation of Semaglutide After Treatment of Recurrent Weight Gain or Suboptimal Response Following Metabolic and Bariatric Surgery
Phase: Phase 4 · Sponsor: General Committee of Teaching Hospitals and Institutes, Egypt · Status: Not yet recruiting
Countries: Egypt
US states: none listed
NCT07755085
GLP-1s in Hip and Knee Arthroplasty
Phase: Phase 4 · Sponsor: Nova Scotia Health Authority · Status: Not yet recruiting
Countries: Canada
US states: none listed
NCT07820722
Assessing Heart and Brain Metabolism in Type II Diabetes Mellitus Patients Using Carbon-13 MRI
Phase: Early phase 1 · Sponsor: Sunnybrook Health Sciences Centre · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT07772960
Semaglutide Dose Effects on Metabolic and Stress Hormone, Craving and Alcohol Use Outcomes
Phase: Phase 1 · Sponsor: Yale University · Status: Not yet recruiting
Countries: United States
US states: Connecticut
NCT07859163
Semaglutide Given Before and After Conversion of Sleeve Gastrectomy to Roux-en-Y Gastric Bypass for Recurrent Weight Gain
Phase: Phase 4 · Sponsor: General Committee of Teaching Hospitals and Institutes, Egypt · Status: Not yet recruiting
Countries: Egypt
US states: none listed
NCT07845500
A Study to Learn About Switching to a Monthly Study Medicine Called Berobenatide (PF-08653944) to Help Keep Weight Off in People With Overweight or Obesity
Phase: Phase 3 · Sponsor: Pfizer · Status: Recruiting
Countries: United States
US states: Alabama, California, Florida, Kentucky, Michigan, Mississippi, Missouri, Montana, North Carolina, Ohio, South Carolina
NCT07845578
A Research Study Looking Into How a High Dose of s.c. Semaglutide Works With Emptying of the Stomach in People With Excess Body Weight
Phase: Phase 1 · Sponsor: Novo Nordisk A/S · Status: Not yet recruiting
Countries: Austria
US states: none listed
NCT07668414
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
Phase: Phase 3 · Sponsor: Novo Nordisk A/S · Status: Recruiting
Countries: United States
US states: California, District of Columbia, Florida, Georgia, Illinois, Indiana, Louisiana, Missouri, New York, North Carolina, North Dakota, Pennsylvania, South Carolina, Texas, Virginia, Washington
Semax
No open trials in the snapshot of .clinicaltrials.gov
Sildenafil
Snapshot of .clinicaltrials.gov
NCT06800092
Sildenafil to Prevent and Reduce Cancer Related Cognitive Impairment
Phase: Phase 2/Phase 3 · Sponsor: The University of Texas Medical Branch, Galveston · Status: Not yet recruiting
Countries: United States
US states: Texas
NCT07039760
Asciminib With or Without Sildenafil for Brain Tumors
Phase: Early phase 1 · Sponsor: Washington University School of Medicine · Status: Not yet recruiting
Countries: United States
US states: Missouri
NCT07647003
A Study to Evaluate the Effect of Two Fixed-Dose Leucine, Sildenafil and Metformin Combinations on Blood Pressure in Individuals With Hypertension
Phase: Phase 2 · Sponsor: NuSirt Biopharma · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT06810284
Sildenafil Plus Hypothermia to Treat Neonatal Encephalopathy
Phase: Phase 2 · Sponsor: Assistance Publique - Hôpitaux de Paris · Status: Not yet recruiting
Countries: France
US states: none listed
NCT07508358
Vaginal Sildenafil for Primary Dysmenorrhea
Phase: Phase 1 · Sponsor: Kevin Hellman · Status: Not yet recruiting
Countries: United States
US states: Illinois
NCT07824674
The Effect of Additive On-Demand Sildenafil vs. Dextrose Candy on Maximum Exercise Capacity in Pulmonary Arterial Hypertension
Phase: Phase 2/Phase 3 · Sponsor: Silvia Ulrich · Status: Recruiting
Countries: Switzerland
US states: none listed
NCT07732387
A Study to Assess the Safety, Tolerability and Pharmacokinetics of Viaca (Sildenafil + Cabergoline) Compared With Sildenafil and Cabergoline
Phase: Phase 1 · Sponsor: Yanping Kong · Status: Not yet recruiting
Countries: Australia
US states: none listed
NCT07713914
Randomized Study of Triple Therapy vs Sildenafil Dose Optimization in Pulmonary Arterial Hypertension
Phase: Phase 4 · Sponsor: University of Sao Paulo General Hospital · Status: Recruiting
Countries: Brazil
US states: none listed
NCT07536880
Effect of Sildenafil on Left Ventricular Function in Pediatric With Primary Dilated Cardiomyopathy
Phase: Not stated · Sponsor: Assiut University · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT07601646
A Single-Arm, Dose Escalation of an Intraurethral Alprostadil Paste for Erectile Dysfunction
Phase: Phase 2 · Sponsor: Ryan Flannigan, MD · Status: Recruiting
Countries: Canada
US states: none listed
NCT07290400
Effect of Moderate Alcohol on Absorption and Onset of Hezkue Sildenafil Suspension
Phase: Phase 2 · Sponsor: Aspargo Labs, Inc · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT07302698
PK and Onset of Hezkue Oral Sildenafil Suspension After Alcohol Consumption
Phase: Phase 1 · Sponsor: Aspargo Labs, Inc · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT07117383
Hezkue®, Hezkue Turbo®, and Commercial Sildenafil Products in Fed Healthy Male Subject
Phase: Phase 1 · Sponsor: Aspargo Labs, Inc · Status: Not yet recruiting
Countries: United States
US states: New York
NCT07231185
Phase 2 Efficacy Study of Sildenafil Products in Adult Men With Erectile Dysfunction
Phase: Phase 2 · Sponsor: Aspargo Labs, Inc · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT07391579
Daily Tadalafil 5 mg Combined With On-Demand Sildenafil 100 mg for Treatment of Erectile Dysfunction in PDE-5I Non Responder Patients
Phase: Phase 4 · Sponsor: Mansoura University · Status: Recruiting
Countries: Egypt
US states: none listed
NCT07177326
Combination Therapy of Tadalafil 2.5mg Plus Sildenafil 25mg Versus Tadalafil 5 mg Monotherapy for Treatment of Erectile Dysfunction: A Randomized, Placebo-Controlled Double-Blinded Cross-Over Study
Phase: Phase 3 · Sponsor: Assiut University · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT06123156
Interest of Early Erectile Rehabilitation With Sildenafil After Radiotherapy and Proctectomy for Rectal Cancer
Phase: Phase 3 · Sponsor: University Hospital, Rouen · Status: Recruiting
Countries: France
US states: none listed
NCT07057011
Therapeutic Outcomes of Selective Serotonin Reuptake Inhibitors and Phosphodiesterase-5 Inhibitors Combination Therapy Versus Monotherapy
Phase: Not applicable · Sponsor: South Valley University · Status: Not yet recruiting
Countries: Egypt
US states: none listed
NCT06839651
Umbilical Cord Mesenchymal Stem Cell Secretome in Severe Erectile Dysfunction Non-responsive to Sildenafil
Phase: Phase 1 · Sponsor: Universitas Indonesia · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT06872866
The Objective of This Phase 1 Study is to Evaluate the Food Effect of 100 mg Hezkue Turbo® (ASP-001.1, Sildenafil) Under Fed Versus 100 mg of Hezkue Turbo® (ASP-001.1, Sildenafil) Under Fasted Conditions in Healthy Adult Male Subjects
Phase: Phase 1 · Sponsor: Aspargo Labs, Inc · Status: Recruiting
Countries: United States
US states: New York
NCT06510322
Sildenafil to Reduce Vascular Remodeling During Left Ventricular Assist Device Support
Phase: Early phase 1 · Sponsor: Montefiore Medical Center · Status: Recruiting
Countries: United States
US states: New York
NCT06797479
Detection of Circulating Therapeutic Monoclonal Antibodies in Biological Samples of Gynecological Cancer Patients.
Phase: Not stated · Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT06954597
Safety and Tolerability of TOP-N53 Applied on Digital Ulcers in Patients With Systemic Sclerosis
Phase: Phase 2 · Sponsor: Topadur Pharma AG · Status: Recruiting
Countries: France, Switzerland
US states: none listed
NCT06782659
Study to Compare the Effects of Viagra® Vs Hezkue® in Healthy Fasted Male Participants.
Phase: Phase 1 · Sponsor: Aspargo Labs, Inc · Status: Not yet recruiting
Countries: United States
US states: Florida
NCT06753981
Efficacy and Safety of Triple-targeted Drug Therapy in Treatment-naive Patients With Non-low-risk PAH: A Real-world, Multicenter Study
Phase: Not stated · Sponsor: Qianfoshan Hospital · Status: Recruiting
Countries: China
US states: none listed
NCT06715280
Switching of Sildenafil to Riociguat in CTEPH Patients
Phase: Phase 4 · Sponsor: Chinese University of Hong Kong · Status: Recruiting
Countries: Hong Kong
US states: none listed
NCT05782244
Sildenafil for Microvasculopathy in Chronic TBI
Phase: Phase 2 · Sponsor: University of Pennsylvania · Status: Recruiting
Countries: United States
US states: Pennsylvania
NCT06098833
Treatment of Neonatal Encephalopathy With Oral Sildenafil Suspension to Repair Brain Injury Secondary to Birth Asphyxia
Phase: Phase 2 · Sponsor: Pia Wintermark · Status: Recruiting
Countries: United States, Canada
US states: Colorado
NCT06324396
IMProving DRug Dosing and Outcomes for Single VEntricle Patients With Fontan Associated Liver Disease
Phase: Phase 1 · Sponsor: Children's Mercy Hospital Kansas City · Status: Recruiting
Countries: United States
US states: Missouri
NCT06875258
PEnile ReHABilitation After Nerve Sparing Robot-assisted Radical Prostatectomy for Prostate Cancer 2.0 (PEHAB-II)
Phase: Phase 4 · Sponsor: The Netherlands Cancer Institute · Status: Recruiting
Countries: Netherlands
US states: none listed
NCT06317805
Initial Triple Therapy Including Parenteral Treprostinil vs Initial Double Oral Therapy in PAH Group I Patients
Phase: Phase 4 · Sponsor: AOP Orphan Pharmaceuticals AG · Status: Recruiting
Countries: Austria, Czechia, France, Germany, Hungary, Italy, Poland, Portugal, Romania, Spain
US states: none listed
NCT05201144
A Trial of Phosphodiesterase-5 Inhibitor in Neonatal Congenital Diaphragmatic Hernia (TOP-CDH)
Phase: Phase 2 · Sponsor: University of Utah · Status: Recruiting
Countries: United States
US states: Utah
NCT05061368
Oral Sildenafil for Exercise Capacity, Dyspnea and Cardiopulmonary Function in COPD
Phase: Phase 2 · Sponsor: University of Alberta · Status: Recruiting
Countries: Canada
US states: none listed
NCT04797286
Sildenafil for Early Pulmonary Vascular Disease in Scleroderma
Phase: Phase 2 · Sponsor: Johns Hopkins University · Status: Recruiting
Countries: United States
US states: Louisiana, Maryland
NCT04898114
Nebulized Magnesium Sulfate and Sildenafil for Persistent Pulmonary Hypertension of Newborn
Phase: Phase 1/Phase 2 · Sponsor: Sohag University · Status: Recruiting
Countries: Egypt
US states: none listed
NCT07377084
Metabolomics of Cancers of the Upper Aerodigestive Tract
Phase: Not stated · Sponsor: Centre Antoine Lacassagne · Status: Recruiting
Countries: France
US states: none listed
NCT01347216
COMPERA / COMPERA-KIDS
Phase: Not stated · Sponsor: Technische Universität Dresden · Status: Recruiting
Countries: Belgium, Germany, Italy, Switzerland
US states: none listed
Tadalafil
Snapshot of .clinicaltrials.gov
NCT07890285
A Study of Opsynvi in Adults Participants With Pulmonary Arterial Hypertension in Korea
Phase: Not stated · Sponsor: Janssen Korea, Ltd., Korea · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT07882901
Effects of Tadalafil on Cognition and Cerebral Hemodynamics in Elderly Patients With Mild Cognitive Impairment
Phase: Phase 2 · Sponsor: Los Angeles Brain Science Project · Status: Not yet recruiting
Countries: United States
US states: California
NCT07537855
Efficacy of Intracavernosal Xeomin With Tadalafil for Mild-Moderate Erectile Dysfunction
Phase: Phase 2 · Sponsor: Northwestern University · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT07576335
Multimodal Prehabilitation and Rehabilitation for Men Undergoing Robot-Assisted Radical Prostatectomy
Phase: Phase 2 · Sponsor: Surgical Outcomes Research Centre (SOuRCe) · Status: Recruiting
Countries: Australia
US states: none listed
NCT07773103
Endothelial Markers and Tadalafil Response
Phase: Not stated · Sponsor: Al-Azhar University · Status: Recruiting
Countries: Egypt
US states: none listed
NCT07753720
Daily Tadalafil as Adjunctive Therapy Versus Monotherapy for PDE5 Inhibitor-Resistant Erectile Dysfunction
Phase: Phase 4 · Sponsor: Al-Azhar University · Status: Recruiting
Countries: Egypt
US states: none listed
NCT07707505
Intracavernosal Exosomes vs. Rectal Ozone for Post-RARP Erectile Dysfunction
Phase: Not applicable · Sponsor: Medipol University · Status: Not yet recruiting
Countries: Turkey (Türkiye)
US states: none listed
NCT07722884
Tamsulosin Monotherapy Versus Combination Therapy With Tadalafil (2.5 mg vs 5 mg) in Managing Male LUTS Secondary to BPH
Phase: Not applicable · Sponsor: Ain Shams University · Status: Recruiting
Countries: Egypt
US states: none listed
NCT07642505
L-Citrulline and Tadalafil for Mild to Moderate Erectile Dysfunction
Phase: Phase 4 · Sponsor: Beni-Suef University · Status: Recruiting
Countries: Egypt
US states: none listed
NCT07654413
Tamsulosin With or Without Tadalafil for Trial Without Catheter After Acute Urinary Retention Due to Benign Prostatic Hyperplasia
Phase: Phase 4 · Sponsor: Beni-Suef University · Status: Recruiting
Countries: Egypt
US states: none listed
NCT07245680
COMMODITIES Trial: Initial Dual Oral Therapy vs Monotherapy in PAH With Cardiovascular Comorbidities
Phase: Phase 3 · Sponsor: Assistance Publique - Hôpitaux de Paris · Status: Recruiting
Countries: France
US states: none listed
NCT07466030
Tadalafil 5 mg on Storage Lower Urinary Tract Symptoms After Anatomical Endoscopic Enucleation of the Prostate
Phase: Phase 1 · Sponsor: Assiut University · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT07117383
Hezkue®, Hezkue Turbo®, and Commercial Sildenafil Products in Fed Healthy Male Subject
Phase: Phase 1 · Sponsor: Aspargo Labs, Inc · Status: Not yet recruiting
Countries: United States
US states: New York
NCT07231185
Phase 2 Efficacy Study of Sildenafil Products in Adult Men With Erectile Dysfunction
Phase: Phase 2 · Sponsor: Aspargo Labs, Inc · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT07562282
Safety and Efficacy of Combination of Tamsulosin 0.4 mg Plus Tadalafil 5mg Versus 2.5 mg
Phase: Not applicable · Sponsor: Ain Shams University · Status: Recruiting
Countries: Egypt
US states: none listed
NCT07391579
Daily Tadalafil 5 mg Combined With On-Demand Sildenafil 100 mg for Treatment of Erectile Dysfunction in PDE-5I Non Responder Patients
Phase: Phase 4 · Sponsor: Mansoura University · Status: Recruiting
Countries: Egypt
US states: none listed
NCT07177326
Combination Therapy of Tadalafil 2.5mg Plus Sildenafil 25mg Versus Tadalafil 5 mg Monotherapy for Treatment of Erectile Dysfunction: A Randomized, Placebo-Controlled Double-Blinded Cross-Over Study
Phase: Phase 3 · Sponsor: Assiut University · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT07172815
PDE5 Inhibitor for Alzheimer's Disease
Phase: Phase 2 · Sponsor: Imperial College London · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT07416968
Randomized Controlled Trial Comparing Low Dose Tadalafil Versus Solifenacin For Management of Overactive Bladder in Women: Multicenter Egyptian National Study
Phase: Phase 4 · Sponsor: Mansoura University · Status: Recruiting
Countries: Egypt
US states: none listed
NCT06968962
Comparison of Sequential to Initial Combination Therapy in PAH
Phase: Not applicable · Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine · Status: Recruiting
Countries: China
US states: none listed
NCT06962462
Daily Tadalafil in Diabetic ED Patients
Phase: Not applicable · Sponsor: South Valley University · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT06753981
Efficacy and Safety of Triple-targeted Drug Therapy in Treatment-naive Patients With Non-low-risk PAH: A Real-world, Multicenter Study
Phase: Not stated · Sponsor: Qianfoshan Hospital · Status: Recruiting
Countries: China
US states: none listed
NCT06583590
Evaluation of Efficacy of Botulinum Toxin A Plus Oral Tadalafil 5 mg in Diabetic Men With Erectile Dysfunction
Phase: Phase 2/Phase 3 · Sponsor: Aswan University Hospital · Status: Recruiting
Countries: Egypt
US states: none listed
NCT06290713
Vasodilator and Exercise Study for DMD (VASO-REx)
Phase: Phase 2 · Sponsor: University of Florida · Status: Recruiting
Countries: United States
US states: Florida
NCT05937854
Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH
Phase: Phase 2 · Sponsor: VA Office of Research and Development · Status: Recruiting
Countries: United States
US states: Colorado, Georgia, Massachusetts, Nebraska, Rhode Island
NCT05844462
Tadalafil for Severe Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease
Phase: Phase 3 · Sponsor: Assistance Publique - Hôpitaux de Paris · Status: Recruiting
Countries: France
US states: none listed
NCT06317805
Initial Triple Therapy Including Parenteral Treprostinil vs Initial Double Oral Therapy in PAH Group I Patients
Phase: Phase 4 · Sponsor: AOP Orphan Pharmaceuticals AG · Status: Recruiting
Countries: Austria, Czechia, France, Germany, Hungary, Italy, Poland, Portugal, Romania, Spain
US states: none listed
NCT05558007
Safety and Efficacy Evaluation of BZ371A Topically Applied on Prostatectomized Patients
Phase: Phase 2 · Sponsor: Biozeus Biopharmaceutical S.A. · Status: Recruiting
Countries: Brazil
US states: none listed
NCT07499804
Effect of Tadalafil on Endometrial Thickness and Frozen Embryo Transfer Outcomes
Phase: Phase 4 · Sponsor: Beni-Suef University · Status: Recruiting
Countries: Egypt
US states: none listed
NCT06717711
Low-Intensity Extracorporeal Shockwave Therapy on Penile Rehabilitation After Robot-assisted Surgical Treatment of Genitourinary Cancers
Phase: Phase 3 · Sponsor: Regina Elena Cancer Institute · Status: Recruiting
Countries: Italy
US states: none listed
NCT05955001
Efficacy of Tadalafil (5mg) For Treatment of Early Storage Symptoms and Erectile Dysfunction After Endoscopic Enucleation of Prostate
Phase: Phase 2/Phase 3 · Sponsor: Mansoura University · Status: Recruiting
Countries: Egypt
US states: none listed
NCT05206955
Study of Tadalafil vs. Placebo for Improving Hemodynamics and End-Organ Dysfunction in Fontan Physiology
Phase: Phase 3 · Sponsor: Mayo Clinic · Status: Recruiting
Countries: United States
US states: Minnesota
NCT05179876
A Study Providing Treatment Access in Participants With Pulmonary Hypertension Completing a Parent Study and Having no Other Option
Phase: Phase 3 · Sponsor: Actelion · Status: Recruiting
Countries: Belarus, Belgium, Bulgaria, China, Hungary, Poland, Russia, South Africa, South Korea, Taiwan, Thailand, Ukraine, Vietnam
US states: none listed
NCT05051436
The Effects of Mirabegron and Tadalafil on Glucose Tolerance in Prediabetics
Phase: Phase 4 · Sponsor: Philip Kern · Status: Recruiting
Countries: United States
US states: Kentucky
TB-500
No open trials in the snapshot of .clinicaltrials.gov
Tesamorelin
Snapshot of .clinicaltrials.gov
NCT07481734
Tesamorelin for Reduction of Liver Fat in Adults With Fatty Liver Disease (Mock Study)
Phase: Phase 2 · Sponsor: Hudson Biotech · Status: Recruiting
Countries: China
US states: none listed
NCT06554717
Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV
Phase: Phase 2 · Sponsor: Massachusetts General Hospital · Status: Recruiting
Countries: United States
US states: Colorado, Massachusetts
NCT03150511
Tesamorelin to Improve Functional Outcomes After Peripheral Nerve Injury
Phase: Phase 2 · Sponsor: Johns Hopkins University · Status: Recruiting
Countries: United States
US states: Maryland
Tesofensine
No open trials in the snapshot of .clinicaltrials.gov
Thymalin
No open trials in the snapshot of .clinicaltrials.gov
Tirzepatide
Snapshot of .clinicaltrials.gov
NCT07265752
Tirzepatide for the Treatment of Cannabis Use Disorder
Phase: Phase 2 · Sponsor: Brigham and Women's Hospital · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT07847515
Effects of Tirzepatide on Gut Microbiota and Gastrointestinal Function After Drug Withdrawal in Obese Patients
Phase: Not stated · Sponsor: Nanjing First Hospital, Nanjing Medical University · Status: Not yet recruiting
Countries: China
US states: none listed
NCT07078838
Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial Cancer
Phase: Phase 2 · Sponsor: UNC Lineberger Comprehensive Cancer Center · Status: Not yet recruiting
Countries: United States
US states: North Carolina
NCT07622992
Preoperative Optimization With Tirzepatide, Ketogenic Diet, or Standard Care Before One Anastomosis Gastric Bypass Surgery
Phase: Not stated · Sponsor: Mario Musella MD · Status: Not yet recruiting
Countries: Italy
US states: none listed
NCT07829198
Efficacy of Tirzepatide for Weight Management in Patients With Suboptimal Weight Loss After Bariatric Surgery: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Phase: Phase 3 · Sponsor: Universidade do Porto · Status: Not yet recruiting
Countries: Portugal
US states: none listed
NCT07787936
GLP-1/GIP Receptor Agonists in Obesity-Related HFpEF: The GLIDE-HF Registry
Phase: Not stated · Sponsor: Miedziowe Centrum Zdrowia SA · Status: Not yet recruiting
Countries: Poland
US states: none listed
NCT07881432
A Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes
Phase: Phase 3 · Sponsor: Eli Lilly and Company · Status: Not yet recruiting
Countries: United States, Argentina, China, Germany, India, Japan, Puerto Rico, South Korea, United Kingdom
US states: Arizona, California, Connecticut, Florida, Georgia, Hawaii, Illinois, Indiana, Louisiana, Maryland, Massachusetts, Mississippi, Nevada, New Mexico, New York, North Carolina, Pennsylvania, Tennessee, Texas, Utah, Virginia
NCT06180616
Tirzepatide for the Treatment of Concurrent Type 1 Diabetes and Overweight or Obesity
Phase: Phase 2 · Sponsor: Royal North Shore Hospital · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT07889648
A Clinical Study to Evaluate the Effects of Enicepatide Versus Tirzepatide in Participants With Type 2 Diabetes and Inadequate Blood Sugar Control on Oral Glucose-Lowering Medications
Phase: Phase 3 · Sponsor: Hoffmann-La Roche · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT07468552
Trial of Tirzepatide for the Treatment of Cannabis Use Disorder
Phase: Phase 2 · Sponsor: National Institute on Drug Abuse (NIDA) · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT07855900
SYNCHRONIZE®-START- A Study to Test Whether Survodutide Helps People Living With Overweight or Obesity Who do Not Have Diabetes to Lose Weight
Phase: Phase 3 · Sponsor: Boehringer Ingelheim · Status: Not yet recruiting
Countries: United States
US states: Florida
NCT07796477
A Study of SYH2069 Injection in Participants With T2DM Not Controlled With Diet/Exercise Alone or Metformin
Phase: Phase 2 · Sponsor: CSPC Ouyi Pharmaceutical Co., Ltd. · Status: Not yet recruiting
Countries: China
US states: none listed
NCT07099742
Effectiveness and Safety of Tirzepatide Among Participants With Obesity With or Without Type 2 Diabetes Mellitus (T2DM)
Phase: Not stated · Sponsor: Dr. Md. Alimur Reza · Status: Not yet recruiting
Countries: Bangladesh
US states: none listed
NCT07881458
A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes
Phase: Phase 3 · Sponsor: Eli Lilly and Company · Status: Not yet recruiting
Countries: United States, Brazil, China, Germany, Japan, Puerto Rico, Romania, South Korea, Spain, Taiwan
US states: Arizona, California, Colorado, Florida, Georgia, Hawaii, Indiana, Louisiana, Missouri, New Jersey, New York, Texas, Virginia, Washington
NCT07878494
Dietary, Medication, and Endoscopic Interventions for Post-Bariatric Hypoglycemia
Phase: Not applicable · Sponsor: Stanford University · Status: Not yet recruiting
Countries: United States
US states: California
NCT07349641
A Study of Weight Loss Intervention With Tirzepatide and Progestin Intrauterine Device to Treat Endometrial Hyperplasia and Grade 1 Endometrial Cancer
Phase: Phase 2 · Sponsor: National Cancer Institute (NCI) · Status: Not yet recruiting
Countries: United States
US states: Illinois, Texas
NCT07609160
Effectiveness of Combined GLP-1/GIP Dual Agonist Therapy and Structured Exercise on Skeletal Muscle Morphology, Quality, and Physical Function in Overweight and Obese Individuals
Phase: Not applicable · Sponsor: Acibadem University · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT07832084
Comparing Different Medication Regimens to Maintaining Weight Loss Among Adults With Obesity Using GLP-1s
Phase: Phase 4 · Sponsor: Jing Luo · Status: Not yet recruiting
Countries: United States
US states: Pennsylvania
NCT07812636
Tirzepatide and Levonorgestrel IUD Therapy for EIN and Early-Stage Endometrial Cancer
Phase: Early phase 1 · Sponsor: Milton S. Hershey Medical Center · Status: Not yet recruiting
Countries: United States
US states: Pennsylvania
NCT07027969
Metabolic Surgery for Atrial Fibrillation Elimination
Phase: Phase 4 · Sponsor: Ali Aminian · Status: Not yet recruiting
Countries: United States
US states: Ohio
NCT07881783
A Real-world Study of Treatment Retention and Adherence to Secukinumab in Patients With Plaque Psoriasis (PsO) With or Without Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) Co-therapy
Phase: Not stated · Sponsor: Novartis Pharmaceuticals · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT07874828
PROACT AYA: Preventing Overweight/Obesity-Associated Cardiotoxicity With Tirzepatide In Adolescent And Young Adult Cancer Survivors - A Phase 2 Single-Arm, Single-Center Feasibility Study
Phase: Phase 2 · Sponsor: M.D. Anderson Cancer Center · Status: Recruiting
Countries: United States
US states: Texas
NCT07868354
A Research Study Investigating How Adults With Overweight or Obesity, With or Without Type 2 Diabetes, Tolerate Switching to a New Treatment (Zenagamtide) From Their Current Tirzepatide Medication
Phase: Phase 1 · Sponsor: Novo Nordisk A/S · Status: Recruiting
Countries: United States
US states: California, Maryland
NCT07777575
Resistance Training to Prevent Muscle Loss During Treatment With Tirzepatide
Phase: Phase 4 · Sponsor: Technical University of Munich · Status: Recruiting
Countries: Germany
US states: none listed
NCT07758231
Impact of GLP-1 Receptor Agonist Therapy on Alcohol Pharmacokinetics
Phase: Phase 1 · Sponsor: University of Wisconsin, Madison · Status: Not yet recruiting
Countries: United States
US states: Wisconsin
NCT07809568
Real-World Outcomes of Tirzepatide in Pakistani Adults With Obesity, Prediabetes, and Type 2 Diabetes
Phase: Not stated · Sponsor: Universiti Sains Malaysia · Status: Not yet recruiting
Countries: Pakistan
US states: none listed
NCT07825857
Randomized Controlled Trial of Tirzepatide for Methamphetamine Use Disorder
Phase: Phase 2 · Sponsor: University of Texas Southwestern Medical Center · Status: Not yet recruiting
Countries: United States
US states: California, Oklahoma, Texas
NCT07782359
Impact of Using a GLP1 on Treatment Related Side Effects of Lung Cancer Patients Receiving Lorlatinib
Phase: Phase 1 · Sponsor: University of Chicago · Status: Not yet recruiting
Countries: United States
US states: Illinois
NCT07846865
Tirzepatide Versus Positive Airway Pressure for the Treatment of Obstructive Sleep Apnoea: A Randomised Comparative Effectiveness Trial
Phase: Phase 2/Phase 3 · Sponsor: Woolcock Institute of Medical Research · Status: Not yet recruiting
Countries: Australia
US states: none listed
NCT07387796
Clinical and Neurobehavioral Changes With Weight Loss Drug Discontinuation and Reinitiation
Phase: Not applicable · Sponsor: The University of Texas at Dallas · Status: Recruiting
Countries: United States
US states: Texas
NCT07845500
A Study to Learn About Switching to a Monthly Study Medicine Called Berobenatide (PF-08653944) to Help Keep Weight Off in People With Overweight or Obesity
Phase: Phase 3 · Sponsor: Pfizer · Status: Recruiting
Countries: United States
US states: Alabama, California, Florida, Kentucky, Michigan, Mississippi, Missouri, Montana, North Carolina, Ohio, South Carolina
NCT07817875
Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS)
Phase: Phase 3 · Sponsor: Eli Lilly and Company · Status: Recruiting
Countries: United States, Belgium, Israel, Italy, Mexico, Poland, Portugal, South Korea, Spain, Taiwan
US states: Arizona, California, Colorado, Connecticut, Florida, Georgia, Illinois, Indiana, Kentucky, Maryland, Massachusetts, Michigan, Minnesota, Nebraska, New York, North Carolina, Ohio, Oklahoma, South Carolina, Tennessee, Texas, Virginia, Washington
NCT07846956
NAION in Non-Diabetic Obese Patients Using GLP-1 Receptor Agonists: A Real-World Study
Phase: Not stated · Sponsor: Istanbul Saglik Bilimleri University · Status: Not yet recruiting
Countries: Turkey (Türkiye)
US states: none listed
NCT07734792
Tirzepatide in Thrombectomy-Treated Acute Ischemic Stroke: A Randomized Trial
Phase: Phase 2/Phase 3 · Sponsor: yifang zhu · Status: Not yet recruiting
Countries: China
US states: none listed
NCT07734870
Tirzepatide for Treatment of CCCA
Phase: Phase 2 · Sponsor: Johns Hopkins University · Status: Recruiting
Countries: United States
US states: Maryland
NCT07803744
A Study of Tirzepatide (LY3298176) in Participants With Type 1 Diabetes Mellitus and Overweight or Obesity
Phase: Phase 1 · Sponsor: Eli Lilly and Company · Status: Recruiting
Countries: United States
US states: Florida
NCT07715929
Effect of Tirzepatide on Recurrence of Atrial Fibrillation After Catheter Ablation in Obese Patients
Phase: Phase 4 · Sponsor: Yunlong Wang · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT07728812
Pragmatic Trial to Study the Cost-Effectiveness of MyPhenome-RX Test to Guide Anti-Obesity Pharmacotherapy
Phase: Not applicable · Sponsor: Phenomix Sciences · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT07811895
Dual GIP/GLP-1 Receptor Agonist in Obese Women Before Frozen Embryo Transfer
Phase: Not applicable · Sponsor: RenJi Hospital · Status: Not yet recruiting
Countries: China
US states: none listed
NCT07756359
Tirzepatide for Ileal Pouch-anal Anastomosis (IPAA) and Chronic High Bowel Frequency (I8F-NS-X008)
Phase: Phase 4 · Sponsor: University of North Carolina, Chapel Hill · Status: Not yet recruiting
Countries: United States
US states: California, Minnesota, Missouri, North Carolina, Utah
NCT07747805
GLP-1 Agonists for Lung Function Improvement and Muscle Restoration in COPD
Phase: Phase 2 · Sponsor: The Cleveland Clinic · Status: Not yet recruiting
Countries: United States
US states: Ohio
NCT07842640
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASC35 Injection in Participants With Obesity or Overweight
Phase: Phase 1 · Sponsor: Ascletis Pharma (China) Co., Limited · Status: Recruiting
Countries: United States
US states: Maryland
NCT07191873
Tirzepatide in Idiopathic Intracranial Hypertension Trial
Phase: Phase 4 · Sponsor: Duke University · Status: Recruiting
Countries: United States
US states: North Carolina
NCT07720466
Salivary Function and Dental Changes During GLP-1 Therapy
Phase: Not stated · Sponsor: Bilecik Seyh Edebali Universitesi · Status: Not yet recruiting
Countries: Turkey (Türkiye)
US states: none listed
NCT06732245
Safety and Efficacy of NA-931 and Tirzepatide in Adults Who Are Overweight or Obese
Phase: Phase 2 · Sponsor: Biomed Industries, Inc. · Status: Not yet recruiting
Countries: United States, Australia, New Zealand
US states: California, Florida, New York, Texas
NCT07728318
Efficacy, Safety, and Treatment Satisfaction of Once-Weekly Tirzepatide in Obese Type 2 Diabetic Patients
Phase: Not applicable · Sponsor: Akhtar Saeed Medical and Dental College · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT07760532
Comparing Facial Aging Between Identical Twins With 3D Imaging
Phase: Not stated · Sponsor: Ponsky Facial Aesthetics And Plastic Surgery, Llc · Status: Not yet recruiting
Countries: United States
US states: Ohio
NCT07554638
Incretin Therapies in Obesity-related HFpEF
Phase: Phase 4 · Sponsor: Columbia University · Status: Recruiting
Countries: United States
US states: New York
NCT07213323
Probiotic Intervention for Digestive Health in Obese Patients Initiating GLP-RA Treatment
Phase: Not applicable · Sponsor: Hospices Civils de Lyon · Status: Recruiting
Countries: France
US states: none listed
NCT07671248
Tirzepatide in the Treatment of Cannabis Use Disorder
Phase: Phase 3 · Sponsor: McMaster University · Status: Not yet recruiting
Countries: Canada
US states: none listed
Tretinoin
Snapshot of .clinicaltrials.gov
NCT07848568
Testing Safe Doses of Anti-Cancer Medicines, 5-Flurouracil (5-FU) and Tretinoin (ATRA), Added to the Usual Cancer Treatment of Ependymoma
Phase: Phase 1/Phase 2 · Sponsor: Children's Oncology Group · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT07842887
Phase 1 Study of ATRA Plus a PD-1 Inhibitor in EGFR-Mutant NSCLC After Third-Generation EGFR-TKI Resistance
Phase: Phase 1 · Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences · Status: Not yet recruiting
Countries: China
US states: none listed
NCT07779811
Topical Metformin Versus Triple Regimen for Epidermal Melasma
Phase: Phase 2 · Sponsor: Combined Military Hospital, Pakistan · Status: Not yet recruiting
Countries: Pakistan
US states: none listed
NCT07732192
Oral Tranexamic Acid Plus Triple Combination vs Triple Combination Alone in Melasma
Phase: Phase 4 · Sponsor: Combined Military Hospital Abbottabad · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT07504458
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
Phase: Phase 3 · Sponsor: Quetzal Therapeutics · Status: Recruiting
Countries: United States, France, Italy, Romania, Spain
US states: Alabama, California, Georgia, Kentucky, Maryland, Michigan, New York, North Carolina, Ohio, Tennessee, Texas, Virginia
NCT07626398
All-Trans Retinoic Acid for the Treatment of Hemophagocytic Lymphohistiocytosis
Phase: Phase 2/Phase 3 · Sponsor: Beijing Anzhen Hospital · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT07597395
ATRA for Management of Primary ITP
Phase: Phase 3 · Sponsor: Peking University People's Hospital · Status: Not yet recruiting
Countries: China
US states: none listed
NCT07348107
ATRA and SDK002 in Combination With Chemotherapy and Anti-PD-1 Inhibitor in Patients With Advanced Pancreatic Ductal Adenocarcinoma.
Phase: Phase 1 · Sponsor: Daniel Breadner · Status: Not yet recruiting
Countries: Canada
US states: none listed
NCT07137130
Secretome TGF Beta 3
Phase: Not applicable · Sponsor: Universitas Indonesia · Status: Not yet recruiting
Countries: Indonesia
US states: none listed
NCT07355855
A Clinical Study on the Efficacy and Safety of All-trans Retinoic Acid Combined With VAC Regimen in the Treatment of Intermediate-to-high-risk Rhabdomyosarcoma
Phase: Phase 2 · Sponsor: Fudan University · Status: Not yet recruiting
Countries: China
US states: none listed
NCT07296445
A Trial to Investigate Whether Oral Arsenic Trioxide Is Similar to Intravenous Arsenic Trioxide in Pharmacokinetics, Safety, and Efficacy (LATITUDE/SDKARS-301)
Phase: Phase 3 · Sponsor: SDK Therapeutics, Inc. · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT07366229
Topical Application of Engineered Lactobacillus Reuteri With a Zinc Sulfate-Tannic Acid MPN Coating for Acne
Phase: Phase 2 · Sponsor: Shenzhen People's Hospital · Status: Recruiting
Countries: China
US states: none listed
NCT07586826
Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gynecologic, Breast, or Lung Solid Tumors
Phase: Phase 2 · Sponsor: Peking University People's Hospital · Status: Recruiting
Countries: China
US states: none listed
NCT07586813
Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gastrointestinal Solid Tumors
Phase: Phase 2 · Sponsor: Peking University People's Hospital · Status: Recruiting
Countries: China
US states: none listed
NCT07278908
Avatrombopag Combined With All-trans Retinoic Acid in the Treatment of Primary Immune Thrombocytopenia
Phase: Phase 2/Phase 3 · Sponsor: Institute of Hematology & Blood Diseases Hospital, China · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT06528769
Study of All-Trans Retinoic Acid (ATRA) and Cemiplimab in Patients With Advanced Leiomyosarcoma
Phase: Phase 2 · Sponsor: Gabriel Tinoco · Status: Recruiting
Countries: United States
US states: Ohio
NCT07154030
Efficacy Of Combined Microneedling Plus Tretinoin In Treatment Of Stria Rubra
Phase: Phase 1 · Sponsor: Sohag University · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT07079696
Investigating the Therapeutic Efficacy of All-trans Retinoic Acid in Autism Spectrum Disorder Patients With 15q11-13 Duplication Syndrome
Phase: Phase 2 · Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine · Status: Not yet recruiting
Countries: China
US states: none listed
NCT07142070
Effect of Systemic Retinoic Acid Use on Micro Ribonucleic Acid (mRNA) Expression
Phase: Not applicable · Sponsor: Medipol University · Status: Not yet recruiting
Countries: Turkey (Türkiye)
US states: none listed
NCT07503730
Early Use of Realgar-Indigo Naturalis Formula (RIF) Combined With All-trans Retinoic Acid (ATRA) for Treating Acute Promyelocytic Leukemia (APL).
Phase: Phase 3 · Sponsor: First Affiliated Hospital Xi'an Jiaotong University · Status: Recruiting
Countries: China
US states: none listed
NCT06925386
The Relationship Between Microbioma Balance and Acne Vulgaris as a New Acne Treatment
Phase: Phase 2 · Sponsor: Universitas Padjadjaran · Status: Not yet recruiting
Countries: Indonesia
US states: none listed
NCT06447480
Clinical Trial to Compare Oral Isotretinoin to Standard of Care in Moderate Acne Skin of Color Patients
Phase: Phase 3 · Sponsor: Centre Hospitalier Universitaire de Nice · Status: Recruiting
Countries: France, French Guiana
US states: none listed
NCT06698263
13-cis Retinoic Acid (Isotretinoin) and Sperm Production
Phase: Phase 4 · Sponsor: University Hospital, Strasbourg, France · Status: Not yet recruiting
Countries: France
US states: none listed
NCT06706401
Lymphocyte-Sparing And Radio-Immunotherapy in Head and Neck Carcinoma
Phase: Phase 3 · Sponsor: Centre Leon Berard · Status: Recruiting
Countries: France
US states: none listed
NCT06358677
Topical Tretinoin Prophylaxis for Anti-EGFR Induced Skin Toxicity in Patients With Solid Tumors
Phase: Phase 2 · Sponsor: University of Utah · Status: Recruiting
Countries: United States
US states: Utah
NCT06780644
Comparison of Effectiveness and Safety of Triple Combination Cream of Fucinolone Acetonide 0.01%, Hydroquinone 4%, Tretinoin 0.05% with Mometasone Furoate 0.1%, Hydroquinone 4%, Tretinoin 0.05% in the Treatment of Melasma
Phase: Not applicable · Sponsor: Universitas Indonesia · Status: Not yet recruiting
Countries: Indonesia
US states: none listed
NCT06841952
Study of Tretinoin Capsules in Combination With Azacitidine and Venetoclax in Treatment Naïve Participants With Acute Myeloid Leukemia
Phase: Not applicable · Sponsor: The First Affiliated Hospital of Soochow University · Status: Not yet recruiting
Countries: China
US states: none listed
NCT06731140
Reverse HER2-negative Immune Resistant Breast Cancer
Phase: Phase 2 · Sponsor: Fudan University · Status: Recruiting
Countries: China
US states: none listed
NCT06646666
ARTA-based Chemo-free Bridging/Maintenance Therapy in CAR-T Treatment for High-Risk R/R B-NHL Ineligible for HDCT and ASCT
Phase: Phase 2 · Sponsor: Ruijin Hospital · Status: Not yet recruiting
Countries: China
US states: none listed
NCT05474859
Subjects With Advanced or Metastatic Solid Tumor Malignancies
Phase: Phase 1 · Sponsor: Xenthera, Inc. · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT06703047
Tislelizumab Combined with Chemotherapy and All Trans Retinoic Acid for Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma
Phase: Phase 2 · Sponsor: Fudan University · Status: Not yet recruiting
Countries: none listed
US states: none listed
NCT06484920
A Phase II Study of the Combination of Pembrolizumab and ATRA Combination Treatment of Relapsed HL and B-NHL
Phase: Phase 2 · Sponsor: Rita Assi · Status: Recruiting
Countries: United States
US states: Indiana
NCT06636981
All Trans Retinoic Acid Combined with Toripalimab+Chemotherapy for Locally Advanced Inoperable or Metastatic Triple Negative Breast Cancer：a Multi-center, Multi-cohort Phase II Trial
Phase: Phase 2 · Sponsor: Fudan University · Status: Recruiting
Countries: China
US states: none listed
NCT06371274
A Study on the Efficacy and Safety of Oral All-trans Retinoic Acid Combined With Toripalimab in TNBC.
Phase: Not applicable · Sponsor: First Affiliated Hospital of Zhejiang University · Status: Recruiting
Countries: China
US states: none listed
NCT06536413
ATRA and Carfilzomib in Plasma Cell Myeloma Patients
Phase: Phase 1/Phase 2 · Sponsor: The Methodist Hospital Research Institute · Status: Recruiting
Countries: United States
US states: Texas
NCT06439888
Lymphocyte Support to SBRT in Patients With Oligo-metastatic Solid Cancer
Phase: Phase 1/Phase 2 · Sponsor: Gustave Roussy, Cancer Campus, Grand Paris · Status: Recruiting
Countries: France
US states: none listed
NCT06172296
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Phase: Phase 3 · Sponsor: National Cancer Institute (NCI) · Status: Recruiting
Countries: United States, Australia, Canada, New Zealand, Puerto Rico
US states: Alabama, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Hawaii, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin
NCT06274164
Clinical and Molecular Biomarker Studies in RAI1 (Retinoic Acid-Induced 1) -Related Disorders
Phase: Not stated · Sponsor: Baylor College of Medicine · Status: Recruiting
Countries: United States
US states: Texas
NCT06158412
All-trans Retinoic Acid in Combination With a KPD Regimen for the Treatment of Refractory/Relapsed Multiple Myeloma
Phase: Phase 2 · Sponsor: The First Affiliated Hospital of Xiamen University · Status: Recruiting
Countries: China
US states: none listed
NCT05553782
Drug Screening Using Novel IMD in Salivary and Head and Neck Cancers
Phase: Early phase 1 · Sponsor: Brigham and Women's Hospital · Status: Recruiting
Countries: United States
US states: Massachusetts
NCT06982274
Oral Arsenic With ATRA for Newly Diagnosed Patients With Acute Promyelocytic Leukemia
Phase: Phase 2 · Sponsor: Instituto do Cancer do Estado de São Paulo · Status: Recruiting
Countries: Brazil
US states: none listed
NCT05881265
Treatment of Chidamide and Venetoclax for Retinoic Acid and Arsenic Resistant Acute Promyelocytic Leukemia
Phase: Phase 2 · Sponsor: Shanghai Jiao Tong University School of Medicine · Status: Recruiting
Countries: China
US states: none listed
NCT05345002
All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition in Recurrent IDH-Mutant Glioma
Phase: Phase 2 · Sponsor: Stephen Bagley, MD, MSCE · Status: Recruiting
Countries: United States
US states: Pennsylvania
NCT05384821
Metronomic Chemotherapy in Wilms Tumor (MetroWilms-1906)
Phase: Phase 1/Phase 2 · Sponsor: Centre Oscar Lambret · Status: Recruiting
Countries: France
US states: none listed
NCT04897490
RWE of 1st Line Treatment With ATO/ATRA for Adult APL
Phase: Not stated · Sponsor: Grupo Argentino de Tratamiento de la Leucemia Aguda · Status: Recruiting
Countries: Argentina
US states: none listed
NCT04793919
Treatment Study for Children and Adolescents With Acute Promyelocytic Leukemia
Phase: Phase 2 · Sponsor: Associazione Italiana Ematologia Oncologia Pediatrica · Status: Recruiting
Countries: Belgium, Czechia, Denmark, France, Germany, Ireland, Israel, Italy, Netherlands, Portugal, Spain, Sweden
US states: none listed
NCT03126916
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Phase: Phase 3 · Sponsor: Children's Oncology Group · Status: Recruiting
Countries: United States, Canada, Puerto Rico
US states: Alabama, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin
NCT01409161
Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
Phase: Phase 2 · Sponsor: M.D. Anderson Cancer Center · Status: Recruiting
Countries: United States
US states: Texas
Vardenafil
No open trials in the snapshot of .clinicaltrials.gov